Transgenic plants expressing a cellulase

ABSTRACT

The instant disclosure describes the application of genetic engineering techniques to produce cellulase in plants. Cellulase coding sequences operably linked to promoters active in plants may be transformed into the nuclear genome and/or the plastid genome of a plant. As cellulases may be toxic to plants, chemically-inducible or wound-inducible promoters may be employed. Additionally, the expressed cellulases may be targeted to vacuoles or other cellular organelles.

CROSS REFERENCE TO RELATED APPLICATIONS

This application is a divisional of U.S. Application Ser. No.09/254,780, filed Mar. 10, 1999 now abandoned, which is a national stageapplication under 35 U.S.C. § 371 of International Application No.PCT/US97/16187, filed Sep. 12, 1997, which claims the benefit of U.S.Provisional Application Ser. No. 60/054,528, filed Aug. 4, 1997, andU.S. Provisional Application Ser. No. 60/025,985, filed Sep. 12, 1996,all of which are herein incorporated by reference in their entireties.

FIELD OF THE INVENTION

The invention relates to the control of gene expression in transgenicplastids and to transgenic plants capable of expressingcellulose-degrading enzymes.

BACKGROUND OF THE INVENTION Industrial Uses for Cellulose-DegradingEnzymes

1. Converting Biomass to Ethanol

The production of ethanol has received considerable attention over theyears as an octane booster, fuel extender, or neat liquid fuel. Forexample, in Brazil, up to 90% of new cars run on neat ethanol, whereasthe remainder run on an ethanol/gasoline blend. In the United States,about 7% of all gasoline sold currently contains ethanol, usually ablend of 90% gasoline:10% ethanol. Fuel ethanol is currently producedprimarily from sugar cane in Brazil; however, in the United States,sugar prices are typically too high to make sugarcane attractive as afeedstock for ethanol production. In the United States, fuel ethanol iscurrently produced primarily from corn and other starch-rich grains.However, the production of one billion gallons of ethanol per yearcorresponds to 400 million bushels of corn per year, which means thatthe existing corn ethanol industry is insufficient to supply the currentfuel market. In addition, corn ethanol is currently too expensive tocost-effectively compete with gasoline. To make a significant impact onthe transportation fuel market, ethanol needs a broader and cheaperresource base than industry currently has at its disposal. Technologyfor utilizing cellulosic biomass, for example wood, grass, and wastebiomass from various commercial processes, as a feedstock could expandthe resource base to accommodate most of the fuel market needs in theUnited States, because cellulosic biomass is cheap and plentiful.

The major components of terrestrial plants are two families of sugarpolymers, cellulose and hemicellulose. Cellulose fibers comprise 4%-50%of the total dry weight of stems, roots, and leaves. These fibers areembedded in a matrix of hemicellulose and phenolic polymers. Celluloseis a polymer composed of six-carbon sugars, mostly glucose, linked byβ-1,4 linkages. Hemicellulose is a polymer of sugars, but the types ofsugars vary with the source of biomass. With the exception of softwoods,the five-carbon sugar xylose is the predominant component inhemicellulose.

While all ethanol production ultimately involves fermentation processesfrom sugars, the technology for ethanol production from cellulosicbiomass is fundamentally different from ethanol production from starchyfood crops. While both require hydrolysis of the feedstock (starch orcellulose) into fermentable sugars, starch is easier to hydrolyze andenzymes that degrade starch, amylases, are relatively inexpensive. Incontrast, cellulose degrading enzymes or “cellulases” are currently lesseffective and more expensive. Hydrolysis of cellulosic biomass tofermentable sugars can also occur though acid hydrolysis processes,which will not be discussed in detail. Cellulases are a family ofenzymes that work in concert to break down cellulose to its simple sugarcomponents under much milder conditions compared to acid hydrolysis. Inaddition, these enzymes catalyze highly specific reactions and arerequired in much smaller quantities compared to acid hydrolysisreactions.

Hydrolysis of cellulose and starch produces glucose by the followingreaction:n C₆H₁₀O₅+n H₂O→n C₆H₁₂O₆

After glucose is formed, fermentation thereof to ethanol proceeds by thefollowing reaction:C₆H₁₂O₆→2 CO₂+2 C₂H₅OH

For lignocellulosic biomass such as hardwoods, the hemicellulosicfraction must also be considered. For biomass predominantly containingthe five-carbon sugar xylose in the hemicellulose, the hydrolysisreaction proceeds as follows:n C₅H₈O₄+n H₂O→n C₅H₁₀O₅whereas the xylose produced is fermented to ethanol with the followingstoichiometry:3 C₅H₁₀O₅→5 CO₂+5 C₂H₅OH2. Other Potential Uses for Cellulose-Degrading Enzymes

In addition to use in converting biomass to ethanol, cellulases havepotential utility in other industrial processes, such as any industrialprocess that depends on a supply of fermentable sugars. Cellulases alsohave potential utility in the pulp and paper industry and in the textileindustry to reduce the current dependency on acid hydrolysis, which is amajor cause of water pollution.

In the animal feed industry, cellulases have utility as a feed additiveto aid the digestion of cellulosic material. Silage, for example, can bemade more digesible by the addition of cellulases or plants whichexpress cellulases.

Characteristics of Cellulose-Degrading Enzymes

As stated above, cellulose and hemicellulose are the principal sourcesof fermentable sugars in lignocellulosic feedstocks; however, nature hasdesigned woody tissue for effective resistance to microbial attack. Awide variety of organisms including bacteria and fungi possesscellulolytic activity. To be effective, cellulose-degradingmicroorganisms typically produce cellulase enzyme systems characterizedby multiple enzymatic activities that work synergistically to reducecellulose to cellobiose, and then to glucose. At least three differentenzymatic activities are required to accomplish this task.β-1,4-endoglucanases (EC 3.2.1.4, also called endocellulases) cleaveβ1,4-glycosidic linkages randomly along the cellulose chain.β-1,4-exoglucanases (EC 3.2.1.91, also called cellobiohydrolases, CBH)cleave cellobiose from either the reducing or the non-reducing end of acellulose chain. 1,4-β-D-glucosidases (EC 3.2.1.21, also calledcellobioses) hydrolyze aryl- and alkyl-β-D-glucosides.

Filamentous fungi are well known as a resource for industrialcellulases. However, this resource is generally regarded as tooexpensive for large scale industrial ethanol production. Some of themost prolific producers of extracellular cellulases are various strainsof Trichoderma reesei. By contrast, cellulases are typically produced bycelluloytic bacteria such as Thermomonospora fusca at much lower levelthan by filamentous fungi. However, cellulases from T. fusca and otherbacteria have been shown to have very high specific activities over abroad pH range and also have the desirable property of thermalstability. The T. fusca genes that encode cellulose-degrading enzymeshave been cloned and extensively characterized. (See, e.g., Collmer etal. (1983) Bio/Technology 1:594-601, hereby incorporated by reference;Ghangas et al. (1988) Appl. Environ. Microbiol. 54:2521-2526, herebyincorporated by reference; and Wilson (1992) Crit. Rev. Biotechnol.12:45-63, hereby incorporated by reference). In addition, the DNAsequences of a cellobiohydrolase gene and an endoglucanase gene from T.fusca have been determined (Jung et al. (1993) AppI. Environ. Microbiol.59:3032-3043, hereby incorporated by reference); and the DNA sequencesof three endoglucanase genes from T. fusca have also been determined(Lao et al. (1991) J. Bacteriol. 173:3397-3407, hereby incorporated byreference).

Efforts are currently being undertaken to utilize recombinantcellulase-producing bacterial or fungal hosts to produce variouscellulases for use in biomass-to-ethanol processes. Candidate cellulasesto be used in such recombinant systems are selected based on factorssuch as kinetics, temperature and pH tolerance, resistance to endproduct inhibition, and their synergistic effects. (See, for example,Thomas et al., “Initial Approaches to Artificial Cellulase Systems forConversion of Biomass to Ethanol”; Enzymatic Degradation of InsolubleCarbohydrates, J. N. Saddler and M. H. Penner, eds., ACS SymposiumSeries 618:208-36, 1995, American Chemical Society, Washington, D.C.,hereby incorporated by reference in its entirety). Examples ofheterologous expression of endoglucanases, exoglucanases, andβ-D-glucosidases in E. coli, Bacillus subtilis, and Streptomyceslividans have been reported (Lejeune et al., Biosynthesis andBiodegradation of Cellulose; Haigler, C. H.; Weimer, P. J., Eds.; MarcelDekker: New York, N.Y., 1990; pp. 623-671). In addition, the expressionof a B. subtilis endoglucanase and a C. fimi β-D-glucosidase in E. colihas been demonstrated (Yoo et al. (1992) Biotechnol. Lett. 14:77-82).

While there is ongoing research to develop a multiple-gene expressionsystem in a suitable host that produces high levels of endoglucanase,exoglucanase, and β-D-glucosidase activities in optimal proportions forthe degradation of cellulosic biomass, the end result of this researchwill be simply be an improved bioreactor for producing large quantitiesof highly active cellulases for use in conventional biomass-to-ethanolprocesses as well as other industrial applications. Thus, this researchis limited by the conventional problems inherent with all suchfermentation processes, including the fact that biomass is naturallyresistant to external enzymatic attack.

Current approaches to this problem are limited to using recombinanthosts that will not themselves be harmed by their genetically-engineeredproduction of cellulose-degrading enzymes. For example, it would beexpected that only hosts that do not themselves include cellulose wouldbe suitable for use in such bioreactors. Plants, therefore, would not beexpected to be suitable hosts for recombinant cellulase genes.Transforming a plant to produce high levels of cellulase iscounterintuitive and presents special technical difficulties. Toovercome these difficulties, it was necessary to develop new expressionsystems, allowing for very high levels of expression, preferably undertight regulation to prevent damage to the plant during its development.These novel expression systems would also have applications beyondcellulase production.

SUMMARY OF THE INVENTION

In a first embodiment, the present invention addresses the need for aplentiful, inexpensive source of cellulose-degrading enzymes for suchindustries as the fuel ethanol production industry, cattle feedindustry, and the paper and textile industries. Accordingly, the presentinvention provides for the production of cellulose-degrading enzymes inplants via the application of genetic engineering techniques. Higherplants make promising candidates for use as in vivo bioreactors forcellulase production. They have high biomass yields, production iseasily scaled up and does not require aseptic conditions, and complexpost-translational modification of plant-synthesized proteins iscommonplace. Moreover, levels of transgene-encoded proteins in plantsmay exceed 1% of total protein content. However, as plants depend oncellulose for structural integrity, it would be expected thatcellulose-degrading enzymes would be toxic to plants. Accordingly,cellulase genes represent an ideal target for technology relating to thechemical induction of gene expression and the targeting of gene productsto cell storage structures.

In the present invention, cellulase coding sequences are fused topromoters active in plants and transformed into the nuclear genome orthe plastid genome. Cellulases that may be expressed in plants accordingto the present invention include, but are not limited to,endoglucanases, exoglucanases, and β-D-glucosidases, preferably derivedfrom non-plant sources such as microorganisms (e.g. bacteria or fungi).A preferred promoter is the chemically-inducible tobacco PR-1a promoter;however, in certain situations, constitutive promoters such as the CaMV35S promoter may be used as well. With a chemically inducible promoter,expression of the cellulase genes transformed into plants may beactivated at an appropriate time by foliar application of a chemicalinducer.

Where plastid transformation is used, vectors are suitably constructedusing a phage promoter, such as the phage T7 gene 10 promoter, thetranscriptional activation of which is dependent upon an RNA polymerasesuch as the phage T7 RNA polymerase. In one case, plastid transformationvectors containing a phage promoter fused to a cellulase gene aretransformed into the chloroplast genome. The resulting line is crossedto a transgenic line containing a nuclear coding region for a phage RNApolymerase supplemented with a chloroplast-targeting sequence andoperably linked to a constitutive promoter such as the CAMV 35Spromoter, resulting in constitutive cellulase expression in thechloroplasts of plants resulting from this cross. Chloroplast expressionhas the advantage that the cellulase is less damaging to the plastid asit contains little or no cellulose.

In addition to using chemically-inducible promoters, the expressedcellulases may be targeted to certain organelles such as vacuoles toalleviate toxicity problems. For vacuole-targeted expression ofcellulases, plants are transfonned with vectors that include a vacuolartargeting sequence such as that from a tobacco chitinase gene. In thiscase, the expressed cellulases will be stored in the vacuoles where theywill not be able to degrade cellulose and harm the plant.

The invention thus provides:

A plant which expresses a cellulose-degrading enzyme, e.g. a cellulosedegrading enzyme not naturally expressed in plants, for example a plantcomprising a heterologous DNA sequence coding for a cellulose degradingenzyme stably integrated into its nuclear or plastid DNA, preferablyunder control of an inducible promoter, e.g., a wound-inducible orchemically-inducible promoter, for example either operably linked to theinducible promoter or under control of transactivator-regulated promoterwherein the corresponding transactivator is under control of theinducible promoter;

also including the seed for such a plant, which seed is optionallytreated (e.g., primed or coated) and/or packaged, e.g. placed in a bagwith instructions for use.

The invention further provides:

A method for producing a cellulose-degrading enzyme comprisingcultivating a cellulase-expressing plant;

a method for producing ethanol comprising fermenting acellulase-expressing plant; and

a method for enhancing the digestibility of animal feed, e.g., silage,comprising adding a cellulase-expressing plant to the feed mix.

These methods may further comprise enhancing cellulose degradation bycombining two or more different cellulose degrading enzymes, e.g.,enzymes acting at different stages in the cellulose biodegradationpathway, e.g., in synergistically active combination, either byexpressing said enzymes in a single plant or by combining two or moreplants each expressing a different cellulose degrading enzyme.

The invention further provides:

A plant expressible expression cassette comprising a coding region for acellulose-degrading enzyme, preferably under control of an induciblepromoter, e.g., a wound inducible or chemically inducible promoter; forexample a plastid expressible expression cassette comprising a promoter,e.g., a transactivator-mediated promoter regulated by a nucleartransactivator (e.g., the T7 promoter when the transactivator is T7 RNApolymerase the expression of which is optionally under control of aninducible promoter), and operably linked to coding region for acellulose-degrading enzyme;

a vector comprising such a plant expressible expression cassette; and

a plant transformed with such a vector, or a transgenic plant whichcomprises in its genome, e.g., its plasstid genome, such a plantexpressible expression cassette.

In a further embodiment, the present invention encompasses a novelsystem of plastid expression, wherein the gene expressed in the plastidis under control of a transactivator-regulated promoter, and the genefor the transactivator is in the nuclear DNA, under control of aninducible promoter. For example, plastid transformation vectors aretypically constructed using a phage promoter, such as the phage T7 gene10 promoter, the transcriptional activation of which is dependent uponan RNA polymerase such as the phage T7 RNA polymerase. The resultingline is crossed to a transgenic line containing a nuclear coding regionfor a phage RNA polymerase supplemented with a chloroplast-targetingsequence and operably linked to a chemically inducible promoter such asthe tobacco PR-1a promoter. Expression of the gene of interest in thechloroplasts of plants resulting from this cross is then activated byfoliar application of a chemical inducer. The novel, inducibletransactivator-mediated plastid expression system described herein isshown to be tightly regulatable, with no detectable expression prior toinduction and exceptionally high expression and accumulation of proteinfollowing induction.

The invention thus additionally provides:

A plant expressible expression cassette comprising an induciblepromoter, e.g., a wound-inducible or chemically-inducible promoter, forexample the tobacco PR-1a promoter, operably linked to a DNA sequencecoding for a transactivator (preferably a transactivator not naturallyoccurring in plants, preferably a RNA polymerase or DNA binding protein,e.g., T7 RNA polymerase), said transactivator being fused to a plastidtargeting sequence, e.g., a chloroplast targeting sequence;

a vector comprising such a plant expressible cassette; and

a plant transformed with such a vector or a transgenic plant the genomeof which comprises such a plant expressible expression cassette.

The invention furthermore provides:

A plant comprising

a heterologous nuclear expression cassette comprising an induciblepromoter, e.g., a wound-inducible or chemically-inducible promoter, forexample the tobacco PR-1a promoter, operably linked to a DNA sequencecoding for a transactivator (preferably a transactivator not naturallyoccurring in plants, preferably a RNA polymerase or DNA binding protein,e.g., T7 RNA polymerase), said transactivator being optionally fused toa plastid targeting sequence, e.g., a chloroplast targeting sequence(e.g., a plant expressible expression cassette as described above); and

a heterologous plastid expression cassette comprising atransactivator-mediated promoter regulated by the transactivator (e.g.,the T7 promoter when the transactivator is T7 RNA polymerase) andoperably linked to a DNA sequence of interest, e.g., coding for aprotein of interest (e.g., an enzyme, a carbohydrate degrading enzyme,for example GUS or a cellulose-degrading enzyme) or for a functional RNAof interest (e.g., antisense RNA);

also including the seed for such a plant, which seed is optionallytreated (e.g., primed or coated) and/or packaged, e.g. placed in a bagor other container with instructions for use.

The invention also comprises:

A method of producing a plant as described above comprising

pollinating a plant comprising a heterologous plastid expressioncassette comprising a transactivator-mediated promoter regulated andoperably linked to a DNA sequence coding for a protein of interest

with pollen from a plant comprising a heterologous nuclear expressioncassette comprising an inducible promoter operably linked to a DNAsequence coding for a transactivator capable of regulating saidtransactivator-mediated promoter;

recovering seed from the plant thus pollinated; and

cultivating a plant as described above from said seed.

DEFINITIONS

“Cellulose-degrading enzymes” are described herein and includecellulases, cellobiohydrolases, cellobioses and other enzymes involvedin breaking down cellulose and hemicellulose into simple sugars such asglucose and xylose. Preferably, the cellulose-degrading enzyme used inthe present invention are of non-plant origin, e.g., of microbialorigin, preferably of bacterial origin, for example from a bacteria ofthe genus Thermomonospora, e.g., from T. fusca.

“Expression cassette” as used herein means a DNA sequence capable ofdirecting expression of a gene in plant cells, comprising a promoteroperably linked to a coding region of interest which is operably linkedto a termination region. The coding region usually codes for a proteinof interest but may also code for a functional RNA of interest, forexample antisense RNA or a nontranslated RNA that, in the sense orantisense direction, inhibits expression of a particular gene, e.g.,antisense RNA. The gene may be chimeric, meaning that at least onecomponent of the gene is heterologous with respect to at least one othercomponent of the gene. The gene may also be one which is naturallyoccurring but has been obtained in a recombinant form useful for genetictransformation of a plant. Typically, however, the expression cassetteis heterologous with respect to the host, i.e., the particular DNAsequence of the expression cassette does not occur naturally in the hostcell and must have been introduced into the host cell or an ancestor ofthe host cell by a transformation event. A “nuclear expression cassette”is an expression cassette which is integrated into the nuclear DNA ofthe host. A “plastid expression cassette” is an expression cassettewhich is integrated into the plastid DNA of the host. A plastidexpression cassette as described herein may optionally comprise apolycistronic operon containing two or more cistronic coding sequencesof interest under control of a single promoter, e.g., atransactivator-mediated promoter, e.g., wherein one of the codingsequences of interest encodes an antisense mRNA which inhibitsexpression of clpP or other plastid protease, thereby enhancingaccumulation of protein expressed the the other coding sequence orsequences of interest.

“Heterologous” as used herein means “of different natural origin”. Forexample, if a plant is transformed with a gene derived from anotherorganism, particularly from another species, that gene is heterologouswith respect to that plant and also with respect to descendants of theplant which carry that gene.

“Homoplastidic” refers to a plant, plant tissue or plant cell whereinall of the plastids are genetically identical. This is the normal statein a plant when the plastids have not been transformed, mutated, orotherwise genetically altered. In different tissues or stages ofdevelopment, the plastids may take different forms, e.g., chloroplasts,proplastids, etioplasts, amyloplasts, chromoplasts, and so forth.

An “inducible promoter” is a promoter which initiates transcription onlywhen the plant is exposed to some particular external stimulus, asdistinguished from constitutive promoters or promoters specific to aspecific tissue or organ or stage of development. Particularly preferredfor the present invention are chemically-inducible promoters andwound-inducible promoters. Chemically inducible promoters includeplant-derived promoters, such as the promoters in the systemic acquiredresistance pathway, for example the PR promoters, e.g., the PR-1, PR-2,PR-3, PR-4, and PR-5 promoters, especially the tobacco PR-1a promoterand the Arabidopsis PR-1 promoter, which initiate transcription when theplant is exposed to BTH and related chemicals. See U.S. Pat. No.5,614,395, incorporated herein by reference, and U.S. ProvisionalApplication No. 60/027,228, incorporated herein by reference.Chemically-inducible promoters also include receptor-mediated systems,e.g., those derived from other organisms, such as steroid-dependent geneexpression, copper-dependent gene expression, tetracycline-dependentgene expression, and particularly the expression system utilizing theUSP receptor from Drosophila mediated by juvenile growth hormone and itsagonists, described in PCT/EP96/04224, incorporated herein by reference,as well as systems utilizing combinations of receptors, e.g., asdescribed in PCT/EP96/00686, incorporated herein by reference. Woundinducible promoters include promoters for proteinase inhibitors, e.g.,the proteinase inhibitor II promoter from potato, and otherplant-derived promoters involved in the wound response pathway, such aspromoters for polyphenyl oxidases, LAP and TD. See generally, C. Gatz,“Chemical Control of Gene Expression”, Annu. Rev. Plant Physiol. PlantMol. Biol. (1997) 48: 89-108, the contents of which are incorporatedherein by reference.

A “plant” refers to any plant or part of a plant at any stage ofdevelopment. In some embodiments of the invention, the plants may belethally wounded to induce expression or may be induced to expresslethal levels of a desired protein, and so the term “plant” as usedherein is specifically intended to encompass plants and plant materialwhich have been seriously damaged or killed, as well as viable plants,cuttings, cell or tissue cultures, and seeds.

A “transactivator” is a protein which, by itself or in combination withone or more additional proteins, is capable of causing transcription ofa coding region under control of a corresponding transactivator-mediatedpromoter. Examples of transactivator systems include phage T7 gene 10promoter, the transcriptional activation of which is dependent upon aspecific RNA polymerase such as the phage T7 RNA polymerase. Thetransactivator is typically an RNA polymerase or DNA binding proteincapable of interacting with a particular promoter to initiatetranscription, either by activating the promoter directly or byinactivating a repressor gene, e.g., by suppressing expression oraccumulation of a repressor protein. The DNA binding protein may be achimeric protein comprising a binding region (e.g., the GAL4 bindingregion) linked to an appropriate transcriptional activator domain. Sometransactivator systems may have multiple transactivators, for examplepromoters which require not only a polymerase but also a specificsubunit (sigma factor) for promotor recognition, DNA binding, ortranscriptional activation. The transactivator is preferablyheterologous with respect to the plant.

DESCRIPTION OF THE FIGURES

FIG. 1 is a schematic description of chimeric gene constructs describedin the Examples for cellulase expression in plants. Hatched boxesrepresent the E5 gene signal sequence and closed boxes represent thevacuolar targeting sequence from a tobacco chitinase gene. T_(n) codesfor nos termination sequences and Ttml for tml termination sequences.

FIG. 2 depicts plastid transformation vectors described in Section C ofthe Examples.

DETAILED DESCRIPTION OF THE INVENTION

The present invention addresses the need for a plentiful, inexpensivesource of cellulose-degrading enzymes for such industries as the fuelethanol production industry, cattle feed industry, and the paper andtextile industries by replacing the conventional industrial cellulasesproduced by fungi with cellulases produced in plants. By geneticallyengineering plants to produce their own cellulases, external applicationof cellulases for cellulose degradation will be unnecessary. Forexample, lignocellulosic biomass destined to become ethanol could serveas its own source of cellulase by utilizing the present invention. Infact, transgenic plants according to the present invention would notnecessarily have to comprise all of the feedstock in a bioreactor;rather, they could be used in conjunction with non-transformedcellulosic feedstock, whereby the cellulases produced by the transgenicplants would degrade the cellulose of all the feedstock, including thenon-transgenic feedstock. Cellulose degradation processes usingtransgenic biomass produced according to the present invention can becarried out more inexpensively, easily, and more environmentally safethan can conventional methods.

The feedstock could be any type of lignocelluosic material such ashigh-biomass plants grown specifically for use as a source of biomass orwaste portions of plants grown primarily for other purposes, such asstems and leaves of crop plants. Plants transformed with cellulase genesmay be transformed with constructs that provide constitutive expressionof cellulases if the particular plants can survive their own productionof cellulases. If a particular type of plant experiences undue toxicityproblems from the constitutive expression of cellulases, then the plantis preferably transformed with constructs that allow cellulaseproduction only when desired. For example, with chemically induciblecellulase constructs, one chemically induces cellulase expression justbefore harvesting plants so that just as the plants are being killed bytheir own production of cellulases, they are harvested anyway. Planttissue is then crushed, ground, or chopped to release the cellulasesthen added to a bioreactor in which the lignocellulosic biomass would bedegraded into simple sugars by the action of the cellulases expressed inthe transgenic plants.

The chimeric genes constructed according to the present invention may betransformed into any suitable plant tissue. As used in conjunction withthe present invention, the term “plant tissue” includes, but is notlimited to, whole plants, plant cells, plant organs, plant seeds,protoplasts, callus, cell cultures, and any groups of plant cellsorganized into structural and/or functional units. Plants transformed inaccordance with the present invention may be monocots or dicots andinclude, but are not limited to, maize, wheat, barley, rye, sweetpotato, bean, pea, chicory, lettuce, cabbage, cauliflower, broccoli,turnip, radish, spinach, asparagus, onion, garlic, pepper, celery,squash, pumpkin, hemp, zucchini, apple, pear, quince, melon, plum,cherry, peach, nectarine, apricot, strawberry, grape, raspberry,blackberry, pineapple, avocado, papaya, mango, banana, soybean, tomato,sorghum, sugarcane, sugarbeet, sunflower, rapeseed, clover, tobacco,carrot, cotton, alfalfa, rice, potato, eggplant, cucumber, Arabidopsis,and woody plants such as coniferous and deciduous trees.

Once a desired gene has been transformed into a particular plantspecies, it may be propagated in that species or moved into othervarieties of the same species, particularly including commercialvarieties, using traditional breeding techniques. Alternatively, thecoding sequence for a desired protein, e.g., a cellulose-degradingenzyme, may be isolated, genetically engineered for optimal expressionand then transformed into the desired variety

Preferred cellulase genes to be transformed into plants according to thepresent invention include, but are not limited to, the T. fusca E1 gene(GenBank accession number L20094) (Jung et al. (1993) AppI. Environ.Microbiol. 59:3032-3043); the T. fusca E2 gene (GenBank accession numberM73321) (Ghangas et al. (1988) Appl. Environ. Microbiol. 54, 2521-2526;Lao et al. (199 1) J. Bacteriol. 173, 3397-3407); and the T. fusca E5gene (GenBank accession number L01577) (Collmer and Wilson (1983)Biotechnology 1, 594-601; Lao et al. (1991) J. Bacteriol. 173,3397-3407). However, other cellulase genes may be transformed intoplants according to the present invention as well, including all of thecellulase genes disclosed in the following references: Collmer et al.(1983) Bio/Technology 1:594-601; Ghangas et al. (1988) Appl. Environ.Microbiol. 54:2521-2526: Wilson (1992) Crit. Rev. Biotechnol. 12:45-63;Jung et al. (1993) Appl. Environ. Microbiol. 59:3032-3043; Lao et al.(1991) J. Bacteriol. 173:3397-3407; and Thomas et al., “InitialApproaches to Artificial Cellulase Systems for Conversion of Biomass toEthanol”; Enzymatic Degradation of Insoluble Carbohydrates, J. N.Saddler and M. H. Penner, eds., ACS Symposium Series 618:208-36, 1995,American Chemical Society, Washington, D.C. These include, but are notlimited to, endoglucanases, exoglucanases, and β-D-glucosidases derivedfrom microorganisms such as bacteria and fungi.

Modification of Microbial Genes to Optimize Nuclear Expression in Plants

If desired, the cloned cellulase genes described in this application canbe modified for expression in transgenic plant hosts. For example, thetransgenic expression in plants of genes derived from microbial sourcesmay require the modification of those genes to achieve and optimizetheir expression in plants. In particular, bacterial ORFs that encodeseparate enzymes but which are encoded by the same transcript in thenative microbe are best expressed in plants on separate transcripts. Toachieve this, each microbial ORF is isolated individually and clonedwithin a cassette which provides a plant promoter sequence at the 5′ endof the ORF and a plant transcriptional terminator at the 3′ end of theORF. The isolated ORF sequence preferably includes the initiating ATGcodon and the terminating STOP codon but may include additional sequencebeyond the initiating ATG and the STOP codon. In addition, the ORF maybe truncated, but still retain the required activity; for particularlylong ORFs, truncated versions which retain activity may be preferablefor expression in transgenic organisms. By “plant promoter” and “planttranscriptional terminator” it is intended to mean promoters andtranscriptional terminators which operate within plant cells. Thisincludes promoters and transcription terminators which may be derivedfrom non-plant sources such as viruses (an example is the CauliflowerMosaic Virus).

In some cases, modification to the ORF coding sequences and adjacentsequence will not be required, in which case it is sufficient to isolatea fragment containing the ORF of interest and to insert it downstream ofa plant promoter. Preferably, however, as little adjacent microbialsequence should be left attached upstream of the ATG and downstream ofthe STOP codon. In practice, such construction may depend on theavailability of restriction sites.

In other cases, the expression of genes derived from microbial sourcesmay provide problems in expression. These problems have been wellcharacterized in the art and are particularly common with genes derivedfrom certain sources such as Bacillus. The modification of such genescan be undertaken using techniques now well known in the art. Thefollowing problems are typical of those that may be encountered:

1. Codon Usage

The preferred codon usage in plants differs from the preferred codonusage in certain microorganisms. Comparison of the usage of codonswithin a cloned microbial ORF to usage in plant genes (and in particulargenes from the target plant) will enable an identification of the codonswithin the ORF which should preferably be changed. Typically plantevolution has tended towards a strong preference of the nucleotides Cand G in the third base position of monocotyledons, whereas dicotyledonsoften use the nucleotides A or T at this position. By modifying a geneto incorporate preferred codon usage for a particular target transgenicspecies, many of the problems described below for GC/AT content andillegitimate splicing will be overcome.

2. GC/AT Content

Plant genes typically have a GC content of more than 35%. ORF sequenceswhich are rich in A and T nucleotides can cause several problems inplants. Firstly, motifs of ATTTA are believed to cause destabilizationof messages and are found at the 3′ end of many short-lived mRNAs.Secondly, the occurrence of polyadenylation signals such as AATAAA atinappropriate positions within the message is believed to causepremature truncation of transcription. In addition, monocotyledons mayrecognize AT-rich sequences as splice sites (see below).

3. Sequences Adiacent to the Initiating Methionine

Plants differ from microorganisms in that their messages do not possessa defined ribosome binding site. Rather, it is believed that ribosomesattach to the 5′ end of the message and scan for the first available ATGat which to start translation. Nevertheless, it is believed that thereis a preference for certain nucleotides adjacent to the ATG and thatexpression of microbial genes can be enhanced by the inclusion of aeukaryotic consensus translation initiator at the ATG. Clontech(1993/1994 catalog, page 210) have suggested the sequence GTCGACCATGGTC(SEQ ID NO:1) as a consensus translation initiator for the expression ofthe E. coli uidA gene in plants. Further, Joshi (NAR 15: 6643-6653(1987)) has compared many plant sequences adjacent to the ATG andsuggests the consensus TAAACAATGGCT (SEQ ID NO:2). In situations wheredifficulties are encountered in the expression of microbial ORFs inplants, inclusion of one of these sequences at the initiating ATG mayimprove translation. In such cases the last three nucleotides of theconsensus may not be appropriate for inclusion in the modified sequencedue to their modification of the second AA residue. Preferred sequencesadjacent to the initiating methionine may differ between different plarspecies. A survey of 14 maize genes located in the GenBank databasprovided the following results:

Position Before the Initiating ATG in 14 Maize Genes: −10 −9 −8 −7 −6 −5−4 −3 −2 −1 C 3 8 4 6 2 5 6 0 10  7 T 3 0 3 4 3 2 1 1 1 0 A 2 3 1 4 3 23 7 2 3 G 6 3 6 0 6 5 4 6 1 5

This analysis can be done for the desired plant species into which thecellulase genes are being incorporated, and the sequence adjacent to theATG modified to incorporate the preferred nucleotides.

4. Removal of Illegitimate Splice Sites

Genes cloned from non-plant sources and not optimized for expression inplants may also contain motifs which may be recognized in plants as 5′or 3′ splice sites, and be cleaved, thus generating truncated or deletedmessages. These sites can be removed using the techniques described inapplication Ser. No. 07/961,944, hereby incorporated by reference.

Techniques for the modification of coding sequences and adjacentsequences are well known in the art. In cases where the initialexpression of a microbial ORF is low and it is deemed appropriate tomake alterations to the sequence as described above, then theconstruction of synthetic genes can be accomplished according to methodswell known in the art. These are, for example, described in thepublished patent disclosures EP 0 385 962 (to Monsanto), EP 0 359 472(to Lubrizol) and WO 93/07278 (to Ciba-Geigy). In most cases it ispreferable to assay the expression of gene constructions using transientassay protocols (which are well known in the art) prior to theirtransfer to transgenic plants.

A major advantage of plastid transformation is that plastids aregenerally capable of expressing bacterial genes without substantialmodification. Coden adaptation, etc. as described above is not required,and plastids are capable of expressing multiple open reading framesunder control of a single promoter.

Construction of Plant Transformation Vectors

Numerous transformation vectors are available for plant transformation,and the genes of this invention can be used in conjunction with any suchvectors. The selection of vector for use will depend upon the preferredtransformation technique and the target species for transformation. Forcertain target species, different antibiotic or herbicide selectionmarkers may be preferred. Selection markers used routinely intransformation include the nptII gene which confers resistance tokanamycin and related antibiotics (Messing & Vierra, Gene 19: 259-268(1982); Bevan et al., Nature 304:184-187 (1983)), the bar gene whichconfers resistance to the herbicide phoSphInothricin (White et al., NuclAcids Res 18: 1062 (1990), Spencer et al. Theor Appl Genet 79:625-631(1990)), the hpt gene which confers resistance to the antibiotichygromycin (Blochinger & Diggelmann, Mol Cell Biol 4: 2929-2931), andthe dhfr gene, which confers resistance to methatrexate (Bourouis etal., EMBO J. 2(7): 1099-1104 (1983)).

1. Construction of Vectors Suitable for Agrobacterium Transformation

Many vectors are available for transformation using Agrobacteriumtumefaciens. These typically carry at least one T-DNA border sequenceand include vectors such as pBIN19 (Bevan, Nucl. Acids Res. (1984)) andpXYZ. Below the construction of two typical vectors is described.

Construction of pCIB200 and pCIB2001: The binary vectors pCIB200 andpCIB2001 are used for the construction of recombinant vectors for usewith Agrobacterium and was constructed in the following manner.pTJS75kan was created by NarI digestion of pTJS75 (Schmidhauser &Helinski, J Bacteriol. 164: 446-455 (1985)) allowing excision of thetetracycline-resistance gene, followed by insertion of an AccI fragmentfrom pUC4K carrying an NPTII (Messing & Vierra, Gene 19: 259-268 (1982);Bevan et al., Nature 304: 184-187 (1983); McBride et al., PlantMolecular Biology 14: 266-276 (1990)). XhoI linkers were ligated to theEcoRV fragment of pCIB7 which contains the left and right T-DNA borders,a plant selectable nos/nptII chimeric gene and the pUC polylinker(Rothstein et al., Gene 53: 153-161 (1987)), and the XhoI-digestedfragment was cloned into SalI-digested pTJS75kan to create pCIB200 (seealso EP 0 332 104, example 19). pCIB200 contains the following uniquepolylinker restriction sites: EcoRI, SstI, KpnI, BglII, XbaI, and SalI.pCIB2001 is a derivative of pCIB200 which created by the insertion intothe polylinker of additional restriction sites. Unique restriction sitesin the polylinker of pCIB2001 are EcoRI, SstI, KpnI, BglII, XbaI, SalI,MluI, BcllI AvrII, ApaI, HpaI, and StuI. pCIB2001, in addition tocontaining these unique restriction sites also has plant and bacterialkanamycin selection, left and right T-DNA borders forAgrobacterium-mediated transformation, the RK2-derived trfA function formobilization between E. coli and other hosts, and the OriT and OriVfunctions also from RK2. The pCIB2001 polylinker is suitable for thecloning of plant expression cassettes containing their own regulatorysignals.

Construction of pCIB10 and Hygromycin Selection Derivatives thereof: Thebinary vector pCIB10 contains a gene encoding kanamycin resistance forselection in plants, T-DNA right and left border sequences andincorporates sequences from the wide host-range plasmid pRK252 allowingit to replicate in both E. coli and Agrobacterium. Its construction isdescribed by Rothstein et al. (Gene 53: 153-161 (1987)). Variousderivatives of pCIB10 have been constructed which incorporate the genefor hygromycin B phosphotransferase described by Gritz et al. (Gene 25:179-188 (1983)). These derivatives enable selection of transgenic plantcells on hygromycin only (pCIB743), or hygromycin and kanamycin(pCIB715, pCIB717).

2. Construction of Vectors Suitable for Non-Agrobacterium Transformation

Transformation without the use of Agrobacterium tumefaciens circumventsthe requirement for T-DNA sequences in the chosen transformation vectorand consequently vectors lacking these sequences can be utilized inaddition to vectors such as the ones described above which contain T-DNAsequences. Transformation techniques which do not rely on Agrobacteriuminclude transformation via particle bombardment, protoplast uptake (e.g.PEG and electroporation) and microinjection. The choice of vectordepends largely on the preferred selection for the species beingtransformed. Below, the construction of some typical vectors isdescribed.

Construction of pCIB3064: pCIB3064 is a pUC-derived vector suitable fordirect gene transfer techniques in combination with selection by theherbicide basta (or phosphinothricin). The plasmid pCIB246 comprises theCaMV 35S promoter in operational fusion to the E. coli GUS gene and theCaMV 35S transcriptional terminator and is described in the PCTpublished application WO 93107278. The 35S promoter of this vectorcontains two ATG sequences 5′ of the start site. These sites weremutated using standard PCR techniques in such a way as to remove theATGs and generate the restriction sites SspI and PvuII. The newrestriction sites were 96 and 37 bp away from the unique SalI site and101 and 42 bp away from the actual start site. The resultant derivativeof pCIB246 was designated pCIB3025. The GUS gene was then excised frompCIB3025 by digestion with SalI and SacI, the termini rendered blunt andreligated to generate plasmid pCIB3060. The plasmid pJIT82 was obtainedfrom the John Innes Centre, Norwich and the a 400 bp SmaI fragmentcontaining the bar gene from Streptomyces viridochromogenes was excisedand inserted into the HpaI site of pCIB3060 (Thompson et al. EMBO J 6:2519-2523 (1987)). This generated pCIB3064 which comprises the bar geneunder the control of the CaMV 35S promoter and terminator for herbicideselection, a gene fro ampicillin resistance (for selection in E. coli)and a polylinker with the unique sites SphI, PstI, HindIII, and BamHI.This vector is suitable for the cloning of plant expression cassettescontaining their own regulatory signals.

Construction of pSOG19 and pSOG35: pSOG35 is a transformation vectorwhich utilizes the E. coli gene dihydrofolate reductase (DHFR) as aselectable marker conferring resistance to methotrexate. PCR was used toamplify the 35S promoter (˜800 bp), intron 6 from the maize AdhI gene(˜550 bp) and 18 bp of the GUS untranslated leader sequence from pSOG10.A 250 bp fragment encoding the E. coli dihydrofolate reductase type IIgene was also amplified by PCR and these two PCR fragments wereassembled with a SacI-PstI fragment from pBI221 (Clontech) whichcomprised the pUC19 vector backbone and the nopaline synthaseterminator. Assembly of these fragments generated pSOG19 which containsthe 35S promoter in fusion with the intron 6 sequence, the GUS leader,the DHFR gene and the nopaline synthase terminator. Replacement of theGUS leader in pSOG19 with the leader sequence from Maize ChloroticMottle Virus (MCMV) generated the vector pSOG35. pSOG19 and pSOG35 carrythe pUC gene for ampicillin resistance and have HindIII, SphI, PstI andEcoRI sites available for the cloning of foreign sequences.

Requirements for Construction of Plant Expression Cassettes

Gene sequences intended for expression in transgenic plants are firstlyassembled in expression cassettes behind a suitable promoter andupstream of a suitable transcription terminator. These expressioncassettes can then be easily transferred to the plant transformationvectors described above.

1. Promoter Selection

The selection of promoter used in expression cassettes will determinethe spatial and temporal expression pattern of the transgene in thetransgenic plant. Selected promoters will express transgenes in specificcell types (such as leaf epidermal cells, meosphyll cells, root cortexcells) or in specific tissues or organs (roots, leaves or flowers, forexample) and this selection will reflect the desired location ofbiosynthesis of the cellulase. Alternatively, the selected promoter maydrive expression of the gene under a light-induced or other temporallyregulated promoter. A further (and preferred) alternative is that theselected promoter be inducible by an external stimulus, e.g.,application of a specific chemical inducer or wounding. This wouldprovide the possibility of inducing cellulase transcription only whendesired.

2. Transcriptional Terminators

A variety of transcriptional terminators are available for use inexpression cassettes. These are responsible for the termination oftranscription beyond the transgene and its correct polyadenylation.Appropriate transcriptional terminators and those which are known tofunction in plants and include the CaMV 35S terminator, the tmlterminator, the nopaline synthase terminator, the pea rbcS E9terminator. These can be used in both monocoylyedons and dicotyledons.

3. Sequences for the Enhancement or Regulation of Expression

Numerous sequences have been found to enhance gene expression fromwithin the transcriptional unit and these sequences can be used inconjunction with the genes of this invention to increase theirexpression in transgenic plants.

Various intron sequences have been shown to enhance expression,particularly in monocotyledonous cells. For example, the introns of themaize AdhI gene have been found to significantly enhance the expressionof the wild-type gene under its cognate promoter when introduced intomaize cells. Intron 1 was found to be particularly effective andenhanced expression in fusion constructs with the chloramphenicolacetyltransferase gene (Callis et al., Genes Develep 1: 1183-1200(1987)). In the same experimental system, the intron from the maizebronze1 gene had a similar effect in enhancing expression. Intronsequences have been routinely incorporated into plant transformationvectors, typically within the non-translated leader.

A number of non-translated leader sequences derived from viruses arealso known to enhance expression, and these are particularly effectivein dicotyledonous cells. Specifically, leader sequences from TobaccoMosaic Virus (TMV, the “Ω-sequence”), Maize Chlorotic Mottle Virus(MCMV), and Alfalfa Mosaic Virus (AMV) have been shown to be effectivein enhancing expression (e.g. Gallie et al. Nucl. Acids Res. 15:8693-8711 (1987); Skuzeski et al. Plant Molec. Biol. 15; 65-79 (1990)).

4. Targeting of the Gene Product Within the Cell

Various mechanisms for targeting gene products are known to exist inplants and the sequences controlling the functioning of these mechanismshave been characterized in some detail. For example, the targeting ofgene products to the chloroplast is controlled by a signal sequencefound at the aminoterminal end of various proteins and which is cleavedduring chloroplast import yielding the mature protein (e.g. Comai et al.J. Biol. Chem. 263: 15104-15109 (1988)). These signal sequences can befused to heterologous gene products to effect the import of heterologousproducts into the chloroplast (van den Broeck et al. Nature 313: 358-363(1985)). DNA encoding for appropriate signal sequences can be isolatedfrom the 5′ end of the cDNAs encoding the RUBISCO protein, the CABprotein, the EPSP synthase enzyme, the GS2 protein and many otherproteins which are known to be chloroplast localized.

Other gene products are localized to other organelles such as themitochondrion and the peroxisome (e.g. Unger et al. Plant Molec. Biol.13: 411-418 (1989)). The cDNAs encoding these products can also bemanipulated to effect the targeting of heterologous gene products tothese organelles. Examples of such sequences are the nuclear-encodedATPases and specific aspartate amino transferase isoforms formitochondria. Targeting to cellular protein bodies has been described byRogers et al. (Proc. Natl. Acad. Sci. USA 82: 6512-6516 (1985)).

In addition, sequences have been characterized which cause the targetingof gene products to other cell compartments. Aminoterminal sequences areresponsible for targeting to the ER, the apoplast, and extracellularsecretion from aleurone cells (Koehler & Ho, Plant Cell 2: 769-783(1990)). Additionally, aminoterminal sequences in conjunction withcarboxyterninal sequences are responsible for vacuolar targeting of geneproducts (Shinshi et al. Plant Molec. Biol. 14: 357-368 (1990)).

By the fusion of the appropriate targeting sequences described above totransgene sequences of interest it is possible to direct the transgeneproduct to any organelle or cell compartment. For chloroplast targeting,for example, the chloroplast signal sequence from the RUBISCO gene, theCAB gene, the EPSP synthase gene, or the GS2 gene is fused in frame tothe aminoterminal ATG of the transgene. The signal sequence selectedshould include the known cleavage site and the fusion constructed shouldtake into account any amino acids after the cleavage site which arerequired for cleavage. In some cases this requirement may be fulfilledby the addition of a small number of amino acids between the cleavagesite and the transgene ATG or alternatively replacement of some aminoacids within the transgene sequence. Fusions constructed for chloroplastimport can be tested for efficacy of chloroplast uptake by in vitrotranslation of in vitro transcribed constructions followed by in vitrochloroplast uptake using techniques described by (Bartlett et al. In:Edelmann et al. (Eds.) Methods in Chloroplast Molecular Biology,Elsevier. pp 1081-1091 (1982); Wasmann et al. Mol. Gen. Genet. 205:446-453 (1986)). These construction techniques are well knownn the artand are equally applicable to mitochondria and peroxisomes. The choiceof targeting which may be required for cellulase genes will depend onthe cellular localization of the precursor required as the startingpoint for a given pathway. This will usually be cytosolic orchloroplastic, although it may is some cases be mitochondrial orperoxisomal.

The above-described mechanisms for cellular targeting can be utilizednot only in conjunction with their cognate promoters, but also inconjunction with heterologous promoters so as to effect a specific celltargeting goal under the transcriptional regulation of a promoter whichhas an expression pattern different to that of the promoter from whichthe targeting signal derives.

Examples of Expression Cassette Construction

The present invention encompasses the expression of cellulase genesunder the regulation of any promoter that is expressible in plants,regardless of the origin of the promoter.

Furthermore, the invention encompasses the use of any plant-expressiblepromoter in conjunction with any further sequences required or selectedfor the expression of the cellulase gene. Such sequences include, butare not restricted to, transcriptional terminators, extraneous sequencesto enhance expression (such as introns [e.g. Adh intron 1], viralsequences [e. g. TMV-Ω]), and sequences intended for the targeting ofthe gene product to specific organelles and cell compartments.

1. Constitutive Expression: the CaMV 35S Promoter

Construction of the plasmid pCGN1761 is described in the publishedpatent application EP 0 392 225 (example 23). pCGN1761 contains the“double” 35S promoter and the tml transcriptional terminator with aunique EcoRI site between the promoter and the terminator and has apUC-type backbone. A derivative of pCGN1761 was constructed which has amodified polylinker which includes NotI and XhoI sites in addition tothe existing EcoRI site. This derivative was designated pCGN1761ENX.pCGN1761ENX is useful for the cloning of cDNA sequences or genesequences (including microbial ORF sequences) within its polylinker forthe purposes of their expression under the control of the 35S promoterin transgenic plants. The entire 35S promoter-gene sequence-tmlterminator cassette of such a construction can be excised by HindIII,SphI, SalI, and XbaI sites 5′ to the promoter and XbaI, BamHI and BglIsites 3′ to the terminator for transfer to transformation vectors suchas those described above. Furthermore, the double 35S promoter fragmentcan be removed by 5′ excision with HindIII, SphI, SalI, XbaI, or PstI,and 3′ excision with any of the polylinker restriction sites (EcoRI,NotI or XhoI) for replacement with another promoter.

2. Modification of pCGN1761ENX by Optimization of the TranslationalInitiation Site

For any of the constructions described in this section, modificationsaround the cloning sites can be made by the introduction of sequenceswhich may enhance translation. This is particularly useful when genesderived from microorganisms are to be introduced into plant expressioncassettes as these genes may not contain sequences adjacent to theirinitiating methionine which may be suitable for the initiation oftranslation in plants. In cases where genes derived from microorganismsare to be cloned into plant expression cassettes at their ATG it may beuseful to modify the site of their insertion to optimize theirexpression. Modification of pCGN1761ENX is described by way of exampleto incorporate one of several optimized sequences for plant expression(e.g. Joshi, supra).

pCGN1761ENX is cleaved with SphI, treated with T4 DNA polymerase andreligated, thus destroying the SphI site located 5′ to the double 35Spromoter. This generates vector pCGN1761ENX/Sph-. pCGN1761ENX/Sph- iscleaved with EcoRI, and ligated to an annealed molecular adaptor of thesequence 5′-AATTCTAAAGCATGCCGATCGG-3′ (SEQ IDNO:3)/5′-AATTCCGATCGGCATGCTTTA-3′ (SEQ ID NO:4). This generates thevector pCGNSENX which incorporates the quasi-optimized planttranslational initiation sequence TAAA-C adjacent to the ATG which isitself part of an SphI site which is suitable for cloning heterologousgenes at their initiating methionine. Downstream of the SphI site, theEcoRI NotI and XhoI sites are retained.

An alternative vector is constructed which utilizes an NcoI site at theinitiating ATG. This vector, designated pCGN1761NENX is made byinserting an annealed molecular adaptor of the sequence5′-AATTCTAAACCATGGCGATCGG-3′ (SEQ ID NO:5)/5′AATTCCGATCGCCATGGTTTA-3′(SEQ ID NO:6) at the pCGN 1761ENX EcoRI site. Thus, the vector includesthe quasi-optimized sequence TAAACC adjacent to the initiating ATG whichis within the NcoI site. Downstream sites are EcoRI NotI. and XhoI.Prior to this manipulation, however, the two NcoI sites in thepCGN1761ENX vector (at upstream positions of the 5′35S promoter unit)are destroyed using similar techniques to those described above for SphIor alternatively using “inside-outside” PCR (Innes et al. PCR Protocols:A guide to methods and applications. Academic Press, New York (1990).This manipulation can be assayed for any possible detrimental effect onexpression by insertion of any plant cDNA or reporter gene sequence intothe cloning site followed by routine expression analysis in plants.

3. Expression Under a Chemically Regulatable Promoter

This section describes the replacement of the double 35S promoter inpCGN1761ENX with any promoter of choice; by way of example, thechemically regulatable PR-1a promoter is described in U.S. Pat. No.5,614,395, which is hereby incorporated by reference in its entirety,and the chemically regulatable Arabidopsis PR-1 promoter is described inU.S. Provisional Application No. 60/027,228, incorporated herein byreference. The promoter of choice is preferably excised from its sourceby restriction enzymes, but can alternatively be PCR-amplified usingprimers which carry appropriate terminal restriction sites. ShouldPCR-amplification be undertaken, then the promoter should be resequencedto check for amplification errors after the cloning of the amplifiedpromoter in the target vector. The chemically regulatable tobacco PR-1apromoter is cleaved from plasmid pCIB1004 (see EP 0 332 104, example 21for construction) and transferred to plasmid pCGN1761ENX. pCIB1004 iscleaved with NcoI and the resultant 3′ overhang of the linearizedfragment is rendered blunt by treatment with T4 DNA polymerase. Thefragment is then cleaved with HindIII and the resultant PR-1a promotercontaining fragment is gel purified and cloned into pCGN1761ENX fromwhich the double 35S promoter has been removed. This is done by cleavagewith XhoI and blunting with T4 polymerase, followed by cleavage withHindIII and isolation of the larger vector-terminator containingfragment into which the pCIB1004 promoter fragment is cloned. Thisgenerates a pCGN1761ENX derivative with the PR-1a promoter and the tmlterminator and an intervening polylinker with unique EcoRI and NotIsites. Selected cellulase genes can be inserted into this vector, andthe fusion products (i.e. promoter-gene-terminator) can subsequently betransferred to any selected transformation vector, including thosedescribed in this application.

Various chemical regulators may be employed to induce expression of thecellulase coding sequence in the plants transformed according to thepresent invention. In the context of the instant disclosure, “chemicalregulators” include chemicals known to be inducers for the PR-1apromoter in plants, or close derivatives thereof. A preferred group ofregulators for the chemically inducible cellulase genes of thisinvention is based on the benzo-1,2,3-thiadiazole (BTH) structure andincludes, but is not limited to, the following types of compounds:benzo-1,2,3-thiadiazolecarboxylic acid,benzo-1,2,3-thiadiazolethiocarboxylic acid,cyanobenzo-1,2,3-thiadiazole, benzo-1,2,3-thiadiazolecarboxylic acidamide, benzo-1,2,3-thiadiazolecarboxylic acid hydrazide,benzo-1,2,3-thiadiazole-7-carboxylic acid,benzo-1,2,3-thiadiazole-7-thiocarboxylic acid,7-cyanobenzo-1,2,3-thiadiazole, benzo-1,2,3-thiadiazole-7-carboxylicacid amide, benzo-1,2,3-thiadiazole-7-carboxylic acid hydrazide, alkylbenzo-1,2,3-thiadiazolecarboxylate in which the alkyl group contains oneto six carbon atoms, methyl benzo-1,2,3-thiadiazole-7-carboxylate,n-propyl benzo-1,2,3-thiadiazole-7-carboxylate, benzylbenzo-1,2,3-thiadiazole-7-carboxylate,benzo-1,2,3-thiadiazole-7-carboxylic acid sec-butylhydrazide, andsuitable derivatives thereof. Other chemical inducers may include, forexample, benzoic acid, salicylic acid (SA), polyacrylic acid andsubstituted derivatives thereof; suitable substituents include loweralkyl, lower alkoxy, lower alkylthio, and halogen. Still another groupof regulators for the chemically inducible DNA sequences of thisinvention is based on the pyridine carboxylic acid structure, such asthe isonicotinic acid structure and preferably the haloisonicotinic acidstructure. Preferred are dichloroisonicotinic acids and derivativesthereof, for example the lower alkyl esters. Suitable regulators of thisclass of compounds are, for example, 2,6-dichloroisonicotinic acid(INA), and the lower alkyl esters thereof, especially the methyl ester.

4. Constitutive Expression: the Actin Promoter

Several isoforms of actin are known to be expressed in most cell typesand consequently the actin promoter is a good choice for a constitutivepromoter. In particular, the promoter from the rice ActI gene has beencloned and characterized (McElroy et al. Plant Cell 2: 163-171 (1990)).A 1.3 kb fragment of the promoter was found to contain all theregulatory elements required for expression in rice protoplasts.Furthermore, numerous expression vectors based on the ActI promoter havebeen constructed specifically for use in monocotyledons (McElroy et al.Mol. Gen. Genet. 231: 150-160 (1991)). These incorporate the ActI-intron1, AdhI 5′ flanking sequence and AdHI-intron 1 (from the maize alcoholdehydrogenase gene) and sequence from the CaMV 35S promoter. Vectorsshowing highest expression were fusions of 35S and the ActI intron orthe ActI 5′ flanking sequence and the ActI intron. Optimization ofsequences around the initiating ATG (of the GUS reporter gene) alsoenhanced expression. The promoter expression cassettes described byMcElroy et al. (Mol. Gen. Genet. 231: 150-160 (1991)) can be easilymodified for the expression of cellulase genes and are particularlysuitable for use in monocotyledonous hosts. For example, promotercontaining fragments can be removed from the McElroy constructions andused to replace the double 35S promoter in pCGN1761ENX, which is thenavailable for the insertion or specific gene sequences. The fusion genesthus constructed can then be transferred to appropriate transformationvectors. In a separate report the rice ActI promoter with its firstintron has also been found to direct high expression in cultured barleycells (Chibbar et al. Plant Cell Rep. 12: 506-509 (1993)).

5. Constitutive Expression: the Ubiquitin Promoter

Ubiquitin is another gene product known to accumulate in many call typesand its promoter has been cloned from several species for use intransgenic plants (e.g. sunflower—Binet et al. Plant Science 79: 87-94(1991), maize—Christensen et al. Plant Molec. Biol. 12: 619-632 (1989)).The maize ubiquitin promoter has been developed in transgenic monocotsystems and its sequence and vectors constructed for monocottransformation are disclosed in the patent publication EP 0 342 926 (toLubrizol). Further, Taylor et al. (Plant Cell Rep. 12: 491495 (1993))describe a vector (pAHC25) which comprises the maize ubiquitin promoterand first intron and its high activity in cell suspensions of numerousmonocotyledons when introduced via microprojectile bombardment. Theubiquitin promoter is suitable for the expression of cellulase genes intransgenic plants, especially monocotyledons. Suitable vectors arederivatives of pAHC25 or any of the transformation vectors described inthis application, modified by the introduction of the appropriateubiquitin promoter and/or intron sequences.

6. Root Specific Expression

Another pattern of expression for the cellulases of the instantinvention is root expression. A suitable root promoter is that describedby de Framond (FEBS 290: 103-106 (1991)) and also in the publishedpatent application EP 0 452 269 (to Ciba-Geigy). This promoter istransferred to a suitable vector such as pCGN1761ENX for the insertionof a cellulase gene and subsequent transfer of the entirepromoter-gene-terminator cassette to a transformation vector ofinterest.

7. Wound Inducible Promoters

Wound-inducible promoters may also be suitable for the expression ofcellulase genes. Numerous such promoters have been described (e.g. Xu etal. Plant Molec. Biol. 22: 573-588 (1993), Logemann et al. Plant Cell 1:151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792(1993), Firek et al. Plant Molec. Biol. 22: 129-142 (1993), Warner etal. Plant J. 3: 191-201 (1993)) and all are suitable for use with theinstant invention. Logemann et al. describe the 5′ upstream sequences ofthe dicotyledonous potato wunl gene. Xu et al. show that a woundinducible promoter from the dicotyledon potato (pin2) is active in themonocotyledon rice. Further, Rohrmeier & Lehle describe the cloning ofthe maize Wipl cDNA which is wound induced and which can be used toisolated the cognate promoter using standard techniques. Similarly,Firek et al. and Warner et al. have described a wound induced gene fromthe monocotyledon Asparagus officinalis which is expressed at localwound and pathogen invasion sites. Using cloning techniques well knownin the art, these promoters can be transferred to suitable vectors,fused to the cellulase genes of this invention, and used to expressthese genes at the sites of plant wounding.

8. Pith-Preferred Expression

Patent Application WO 93/07278 (to Ciba-Geigy) describes the isolationof the maize trpA gene which is preferentially expressed in pith cells.The gene sequence and promoter extend up to −1726 from the start oftranscription are presented. Using standard molecular biologicaltechniques, this promoter or parts thereof, can be transferred to avector such as pCGN1761 where it can replace the 35S promoter and beused to drive the expression of a foreign gene in a pith-preferredmanner. In fact, fragments containing the pith-preferred promoter orparts thereof can be transferred to any vector and modified for utilityin transgenic plants.

9. Leaf-Specific Expression

A maize gene encoding phosphoenol carboxylase (PEPC) has been describedby Hudspeth & Grula (Plant Molec Biol 12: 579-589 (1989)). Usingstandard molecular biological techniques the promoter for this gene canbe used to drive the expression of any gene in a leaf-specific manner intransgenic plants.

10. Expression with Chloroplast Targeting

Chen & Jagendorf (J. Biol. Chem. 268: 2363-2367 (1993) have describedthe successful use of a chloroplast transit peptide for import of aheterologous transgene. This peptide used is the transit peptide fromthe rbcS gene from Nicotiana plumbaginifolia (Poulsen et al. Mol. Gen.Genet. 205: 193-200 (1986)). Using the restriction enzymes DraI andSphI, or Tsp509I and SphI the DNA sequence encoding this transit peptidecan be excised from plasmid prbcS-8B and manipulated for use with any ofthe constructions described above. The DraI-SphI fragment extends from−58 relative to the initiating rbcS ATG to, and including, the firstamino acid (also a methionine) of the mature peptide immediately afterthe import cleavage site, whereas the Tsp509I-SphI fragment extends from−8 relative to the initiating rbcS ATG to, and including, the firstamino acid of the mature peptide. Thus, these fragments can beappropriately inserted into the polylinker of any chosen expressioncassette generating a transcriptional fusion to the untranslated leaderof the chosen promoter (e.g. 35S, PR-1a, actin, ubiquitin etc.), whilstenabling the insertion of a cellulase gene in correct fusion downstreamof the transit peptide. Constructions of this kind are routine in theart. For example, whereas the DraI end is already blunt, the 5′ Tsp509Isite may be rendered blunt by T4 polymerase treatment, or mayalternatively be ligated to a linker or adaptor sequence to facilitateits fusion to the chosen promoter. The 3′ SphI site may be maintained assuch, or may alternatively be ligated to adaptor of linker sequences tofacilitate its insertion into the chosen vector in such a way as to makeavailable appropriate restriction sites for the subsequent insertion ofa selected cellulase gene. Ideally the ATG of the SphI site ismaintained and comprises the first ATG of the selected cellulase gene.Chen & Jagendorf provide consensus sequences for ideal cleavage forchloroplast import, and in each case a methionine is preferred at thefirst position of the mature protein. At subsequent positions there ismore variation and the amino acid may not be so critical. In any case,fusion constructions can be assessed for efficiency of import in vitrousing the methods described by Bartlett et al. (In: Edelmann et al.(Eds.) Methods in Chloroplast Molecular Biology, Elsevier. pp 1081-1091(1982)) and Wasmann et al. (Mol. Gen. Genet. 205: 446453 (1986)).Typically the best approach may be to generate fusions using theselected cellulase gene with no modifications at the aminoterminus, andonly to incorporate modifications when it is apparent that such fusionsare not chloroplast imported at high efficiency, in which casemodifications may be made in accordance with the established literature(Chen & Jagendorf; Wasman et al.; Ko & Ko, J. Biol. Chem. 267:13910-13916 (1992)).

A preferred vector is constructed by transferring the DraI-SphI transitpeptide encoding fragment from prbcS-8B to the cloning vectorpCGN1761ENX/SPh. This plasmid is cleaved with EcoRI and the terminirendered blunt by treatment with T4 DNA polymerase. Plasmid prbcS-8B iscleaved with SphI and ligated to an annealed molecular adaptor of thesequence 5′-CCAGCTGGAATTCCG-3′ (SEQ ID NO:7)/5′-CGGAATTCCAGCTGGCATG-3′(SEQ ID NO:8). The resultant product is 5′-terminally phosphorylated bytreatment with T4 kinase. Subsequent cleavage with DraI releases thetransit peptide encoding fragment which is ligated into the blunt-endex-EcoRI sites of the modified vector described above. Clones orientedwith the 5′ end of the insert adjacent to the 3′ end of the 35S promoterare identified by sequencing. These clones carry a DNA fusion of the 35Sleader sequence to the rbcS-8A promoter-transit peptide sequenceextending from −58 relative to the rbcS ATG to the ATG of the matureprotein, and including at that position a unique SphI site, and a newlycreated EcoRI site, as well as the existing NotI and XhoI sites ofpCGN1761ENX. This new vector is designate pCGN 1761/CT. DNA sequencesare transferred to pCGN1761/CT it frame by amplification using PCRtechniques and incorporation of at SphI, NSphI, or NlaIII site at theamplified ATG, which following restriction enzyme cleavage with theappropriate enzyme is ligated into SphI-cleaved pCGN1761/CT. Tofacilitate construction, it may be required to change the second aminoacid of cloned gene, however, in almost all cases the use of PCRtogether with standard site directed mutagenesis will enable theconstruction of any desired sequence around the cleavage site and firstmethionine of the mature protein.

A further preferred vector is constructed by replacing the double 35Spromoter of pCGN1761ENX with the BamHI-SphI fragment of prbcS-8A whichcontains the full-length light regulated rbcS-8A promoter from −1038(relative to the transcriptional start site) up to the first methionineof the mature protein. The modified pCGN1761 with the destroyed SphIsite is cleaved with PstI and EcoRI and treated with T4 DNA polymeraseto render termini blunt. prbcS-8A is cleaved SphI and ligated to theannealed molecular adaptor of the sequence described above. Theresultant product is 5′-terminally phosphorylated by treatment with T4kinase. Subsequent cleavage with BamHI releases the promoter-transitpeptide containing fragment which is treated with T4 DNA polymerase torender the BamHI terminus blunt. The promoter-transit peptide fragmentthus generated is cloned into the prepared pCGN1761ENX vector,generating a construction comprising the rbcS-8A promoter and transitpeptide with an SphI site located at the cleavage site for insertion ofheterologous genes. Further, downstream of the SphI site there are EcoRI(re-created), NotI, and XhoI cloning sites. This construction isdesignated pCGN1761 rbcS/CT.

Similar manipulations can be undertaken to utilize other GS2 chloroplasttransit peptide encoding sequences from other sources (monocotyledonousand dicotyledonous) and from other genes. In addition, similarprocedures can be followed to achieve targeting to other subcellularcompartments such as mitochondria.

Transformation of Dicotyledons

Transformation techniques for dicotyledons are well known in the art andinclude Agrobacterium-based techniques and techniques which do notrequire Agrobacterium. Non-Agrobacterium techniques involve the uptakeof exogenous genetic material directly by protoplasts or cells. This canbe accomplished by PEG or electroporation mediated uptake, particlebombardment-mediated delivery, or microinjection. Examples of thesetechniques are described by Paszkowski et al., EMBO J 3: 2717-2722(1984), Potrykus et al., Mol. Gen. Genet. 199: 169-177 (1985), Reich etal., Biotechnology 4: 1001-1004 (1986), and Klein et al., Nature 327:70-73 (1987). In each case the transformed cells are regenerated towhole plants using standard techniques known in the art.

Agrobacterium-mediated transformation is a preferred technique fortransformation of dicotyledons because of its high efficiency oftransformation and its broad utility with many different species. Themany crop species which are routinely transformable by Agrobacteriuminclude tobacco, tomato, sunflower, cotton, oilseed rape, potato,soybean, alfalfa and poplar (EP 0 317 511 (cotton [1313]), EP 0 249 432(tomato, to Calgene), WO 87107299 (Brassica, to Calgene), U.S. Pat. No.4,795,855 (poplar)). Agrobacterium transformation typically involves thetransfer of the binary vector carrying the foreign DNA of interest (e.g.pCIB2000 or pCIB2001) to an appropriate Agrobacterium strain which maydepend of the complement of vir genes carried by the host Agrobacteriumstrain either on a co-resident Ti plasmid or chromosomally (e.g. strainCIB542 for pCIB200 and pCIB2001 (Uknes et al. Plant Cell 5: 159-169(1993)). The transfer of the recombinant binary vector to Agrobacteriumis accomplished by a triparental mating procedure using E. coli carryingthe recombinant binary vector, a helper E. coli strain which carries aplasmid such as pRK2013 and which is able to mobilize the recombinantbinary vector to the target Agrobacterium strain. Alternatively, therecombinant binary vector can be transferred to Agrobacterium by DNAtransformation (Höbfgen & Willmitzer, Nucl. Acids Res. 16: 9877(1988)).

Transformation of the target plant species by recombinant Agrobacteriumusually involves co-cultivation of the Agrobacterium with explants fromthe plant and follows protocols well known in the art. Transformedtissue is regenerated on selectable medium carrying the antibiotic orherbicide resistance marker present between the binary plasmid T-DNAborders.

Transformation of Monocotyledons

Transformation of most monocotyledon species has now also becomeroutine. Preferred techniques include direct gene transfer intoprotoplasts using PEG or electroporation techniques, and particlebombardment into callus tissue. Transformations can be undertaken with asingle DNA species or multiple DNA species (i.e. co-transformation) andboth these techniques are suitable for use with this invention.Co-transformation may have the advantage of avoiding complex vectorconstruction and of generating transgenic plants with unlinked loci forthe gene of interest and the selectable marker, enabling the removal ofthe selectable marker in subsequent generations, should this be regardeddesirable. However, a disadvantage of the use of co-transformation isthe less than 100% frequency with which separate DNA species areintegrated into the genome (Schocher et al. Biotechnology 4: 1093-1096(1986)).

Patent Applications EP 0 292 435 ([1280/1281] to Ciba-Geigy), EP 0 392225 (to Ciba-Geigy) and WO 93/07278 (to Ciba-Geigy) describe techniquesfor the preparation of callus and protoplasts from an elite inbred lineof maize, transformation of protoplasts using PEG or electroporation,and the regeneration of maize plants from transformed protoplasts.Gordon-Kamm et al. (Plant Cell 2: 603-618 (1990)) and Fromm et al.(Biotechnology 8: 833-839 (1990)) have published techniques fortransformation of A188-derived maize line using particle bombardment.Furthermore, application WO 93/07278 (to Ciba-Geigy) and Koziel et al.(Biotechnology 11: 194-200 (1993)) describe techniques for thetransformation of elite inbred lines of maize by particle bombardment.This technique utilizes immature maize embryos of 1.5-2.5 mm lengthexcised from a maize ear 14-15 days after pollination and a PDS-1000HeBiolistics device for bombardment.

Transformation of rice can also be undertaken by direct gene transfertechniques utilizing protoplasts or particle bombardment.Protoplast-mediated transformation has been described for Japonica-typesand Indica-types (Zhang et al., Plant Cell Rep 7: 379-384 (1988);Shimamoto et al. Nature 338: 274-277 (1989); Datta et al. Biotechnology8: 736-740 (1990)). Both types are also routinely transformable usingparticle bombardment (Christou et al. Biotechnology 9: 957-962 (1991)).

Patent Application EP 0 332 581 (to Ciba-Geigy) describes techniques forthe generation, transformation and regeneration of Pooideae protoplasts.These techniques allow the transformation of Dactylis and wheat.Furthermore, wheat transformation was been described by Vasil et al.(Biotechnology 10: 667-674 (1992)) using particle bombardment into cellsof type C long-term regenerable callus, and also by Vasil et al.(Biotechnology 11: 1553-1558 (1993)) and Weeks et al. (Plant Physiol.102: 1077-1084 (1993)) using particle bombardment of immature embryosand immature embryo-derived callus. A preferred technique for wheattransformation, however, involves the transformation of wheat byparticle bombardment of immature embryos and includes either a highsucrose or a high maltose step prior to gene delivery. Prior tobombardment, any number of embryos (0.75-1 mm in length) are plated ontoMS medium with 3% sucrose (Murashiga & Skoog, Physiologia Plantarum 15:473-497 (1962)) and 3 mg/l 2,4-D for induction of somatic embryos whichis allowed to proceed in the dark. On the chosen day of bombardment,embryos are removed from the induction medium and placed onto theosmoticum (i.e. induction medium with sucrose or maltose added at thedesired concentration, typically 15%). The embryos are allowed toplasmolyze for 2-3 h and are then bombarded. Twenty embryos per targetplate is typical, although not critical. An appropriate gene-carryingplasmid (such as pCIB3064 or pSG35) is precipitated onto micrometer sizegold particles using standard procedures. Each plate of embryos is shotwith the DuPont Biolistics® helium device using a burst pressure of˜1000 psi using a standard 80 mesh screen. After bombardment, theembryos are placed back into the dark to recover for about 24 h (stillon osmoticum). After 24 hrs, the embryos are removed from the osmoticumand placed back onto induction medium where they stay for about a monthbefore regeneration. Approximately one month later the embryo explantswith developing embryogenic callus are transferred to regenerationmedium (MS+1 mg/liter NAA, 5 mg/liter GA), further containing theappropriate selection agent (10 mg/l basta in the case of pCIB3064 and 2mg/l methotrexate in the case of pSOG35). After approximately one month,developed shoots are transferred to larger sterile containers known as“GA7s” which contained half-strength MS, 2% sucrose, and the sameconcentration of selection agent. Patent application No. 08/147,161describes methods for wheat transformation and is hereby incorporated byreference.

Chloroplast Transformation

Plastid transformation technology is extensively described in U.S. Pat.Nos. 5,451,513, 5,545,817, and 5,545,818, all of which are herebyexpressly incorporated by reference in their entireties; in PCTapplication no. WO 95/16783, which is hereby incorporated by referencein its entirety; and in McBride et al. (1994) Proc. Natl. Acad. Sci. USA91, 7301-7305, which is also hereby incorporated by reference in itsentirety. The basic technique for chloroplast transformation involvesintroducing regions of cloned plastid DNA flanking a selectable markertogether with the gene of interest into a sutable target tissue, e.g.,using biolistics or protoplast transformation (e.g., calcium chloride orPEG mediated transformation). The 1 to 1.5 kb flanking regions, termedtargeting sequences, facilitate homologous recombination with theplastid genome and thus allow the replacement or modification ofspecific regions of the plastome. Initially, point mutations in thechloroplast 16S rRNA and rps12 genes conferring resistance tospectinomycin andlor streptomycin were utilized as selectable markersfor transformation (Svab, Z., Hajdukiewicz, P., and Maliga, P. (1990)Proc. Natl. Acad. Sci. USA 87, 8526-8530, hereby incorporated byreference; Staub, J. M., and Maliga, P. (1992) Plant Cell 4, 39-45,hereby incorporated by reference). This resulted in stable homoplasmictransformants at a frequency of approximately one per 100 bombardmentsof target leaves. The presence of cloning sites between these markersallowed creation of a plastid targeting vector for introduction offoreign genes (Staub, J. M., and Maliga, P. (1993) EMBO J. 12, 601-606,hereby incorporated by reference). Substantial increases intransformation frequency were obtained by replacement of the recessiverRNA or r-protein antibiotic resistance genes with a dominant selectablemarker, the bacterial aadA gene encoding the spectinomycin-detoxifyingenzyme aminoglycoside-3′-adenyltransferase (Svab, Z., and Maliga, P.(1993) Proc. Natl. Acad. Sci. USA 90, 913-917, hereby incorporated byreference). Previously, this marker had been used successfully forhigh-frequency transformation of the plastid genome of the green algaChlamydomonas reinhardtii (Goldschmidt-Clermont, M. (1991) Nucl. AcidsRes. 19, 4083-4089, hereby incorporated by reference). Other selectablemarkers useful for plastid transformation are known in the art andencompassesd within the scope of the invention. Typically, approximately15-20 cell division cycles following transformation are required toreach a homoplastidic state.

Plastid expression, in which genes are inserted by homologousrecombination into all of the several thousand copies of the circularplastid genome present in each plant cell, takes advantage of theenormous copy number advantage over nuclear-expressed genes to permitexpression levels that can readily exceed 10% of the total soluble plantprotein. However, such high expression levels may pose potentialviability problems, especially during early plant growth anddevelopment. Similar problems are posed by the expression of bioactiveenzymes or proteins that may be highly deleterious to the survival oftransgenic plants and henced if expressed constitutively may not beintroduced successfully into the plant genome. Thus, in one aspect, thepresent invention has coupled expression in the nuclear genome of achoroplast-targeted phage T7 RNA polymerase under control of thechemically inducible PR-1a promoter (U.S. Pat. No. 5,614,395incorporated by reference) of tobacco to a chloroplast reportertransgene regulated by T7 gene 10 promoter/terminator sequences. Forexample, when plastid transformants homoplasmic for the maternallyinherited uidA gene encoding the β-glucuronidase (GUS) reporter arepollinated by lines expressing the T7 polymerase in the nucleus, F1plants are obtained that carry both transgene constructs but do notexpress the GUS protein. Synthesis of large amounts of enzymaticallyactive GUS is triggered in plastids of these plants only after foliarapplication of the PR-1a inducer compoundbenzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester (BTH). As setforth below in Section C of the Examples, the present invention alsoentails the synthesis of large amounts of cellulose-degrading enzymesusing this chloroplast-targeted T7 RNA polymerase expression system.

The invention will be further described by reference to the followingdetailed examples. These examples are provided for purposes ofillustration only, and are not intended to be limiting unless otherwisespecified.

EXAMPLES

Standard recombinant DNA and molecular cloning techniques used here arewell known in the art and are described by J. Sambrook, E. F. Fritschand T. Maniatis, Molecular Cloning: A Laboratory manual, Cold SpringHarbor laboratory, Cold Spring Harbor, N.Y. (1989) and by T. J. Silhavy,M. L. Berman, and L. W. Enquist, Experiments with Gene Fusions, ColdSpring Harbor Laboratory, Cold Spring Harbor, N.Y. (1984) and byAusubel, F. M. et al., Current Protocols in Molecular Biology, pub. byGreene Publishing Assoc. and Wiley-Interscience (1987).

A. Expression of Cellulases in the Plant Cytosol

Example A1 Preparation of a Chimeric Gene Containing the T. fusca E1Cellulase Coding Sequence Fused to the Tobacco PR-1a Promoter

Plasmid pGFE1 (Jung et al. (1993) Appl. Environ. Microbiol. 59,3032-3043) containing the T. fusca E1 gene (GenBank accession numberL20094), which codes for a protein with endoglucanase activity, was usedas the template for PCR with a left-to-right “top strand” primercomprising an ATG before the first codon of the mature E1 protein, thefirst 21 base pairs of the mature protein and a NcoI restriction site atthe newly created ATG (primer E11: GCG CCC ATG GAC GAA GTC AAC CAG ATTCGC) (SEQ ID NO:9) and a right-to-left “bottom strand” primer homologousto positions 322 to 346 from the newly created ATG of the E1 gene(primer E12: CCA GTC GAC GTT GGA GGT GAA GAC) (SEQ ID NO:10). This PCRreaction was undertaken with AmpliTaq DNA polymerase according to themanufacturer's recommendations (Perkin Elmer/Roche, Branchburg, N.J.)for five cycles at 94° C. (30 s), 40° C. (60 s), and 72° C. (30 s)followed by 25 cycles at 94° C. (30 s), 55° C. (60 s) and 72° C. (30 s).This generated a product of 352 bp containing a NcoI site at its leftend and a EcoRI site at its right end and comprised the 5′ end of the E1gene without the signal sequence. The fragment was gel purified usingstandard procedures, cleaved with NcoI and EcoRI (all restrictionenzymes purchased from Promega, Madison, Wis. or New England Biolabs,Beverly, Mass.) and ligated into the NcoI and EcoRI sites of pTC191 (DeLa Fuente el al. (1994) Gene 139, 83-86) to obtain pE1.

Plasmid pGFE1 was then digested with EcoRI and ScaI. The 3.0 kb longEcoRI fragment containing the 3′ end of the E1 gene was gel purified andligated with pE1, which had previously been digested with EcoRI, toobtain pCTEI containing the entire E1 gene without a signal sequence.Plasmid pCTE1 was digested with NcoI and SacI. The 3.3 kb long fragmentcontaining the E1 gene was gel purified and ligated into the NcoI andSacI sites of pJG203 between a 903 bp long tobacco PR-1a promoter andthe nos gene termination signals (Uknes et al. (1993), The Plant Cell5,159-169, modified by removal of an additional SacI site, JoernGoerlach, notebook no. 2941, pp 4-9 and 13-15), yielding pTPRIE1containing the E1 gene fused to the tobacco PR-1a promoter (FIG. 1).

Plasmid pTPRIE1 was digested with XhoI and XbaI and the 4.5 kb longfragment containing the chimeric E1 gene construct was gel purified andligated into the XhoI and XbaI sites of pBHYGM to obtain binary vectorpEGL101. pBHYGM is a modified pGPTV-Hyg vector (Becker et al. (1992)Plant Mol. Biol. 20, 1195-1197) produced by insertion of a polylinkercontaining BfrI/ApaI/ClaI/SmaI/BfrI/XbaI/SalI/PstI/SphI/HindIIIrestriction sites into the EcoRI and XbaI sites of pGPTV-Hyg.

Example A2 Preparation of a Chimeric Gene Containing the T. fusca E2cellulase Coding Sequence Fused to the Tobacco PR-1a Promoter

Plasmid pJT17 containing the T. fusca E2 gene (Ghangas et al. (1988)Appl. Environ. Microbiol. 54, 2521-2526; Lao et al. (1991) J. Bacteriol.173, 3397-3407) (GenBank accession number M73321), which codes for aprotein with cellobiohydrolase activity, was used as the template forPCR with a left-to-right “top strand” primer comprising an ATG beforethe last codon of the E2 signal sequence, the first 18 base pairs of themature protein and a NcoI restriction site at the newly created ATG(primer E21: GCG CGC CAT GGC CAA TGA TTC TCC GTT CTA C) (SEQ ID NO:11)right-to-left “bottom strand” primer homologous to positions 310 to 334from the newly created ATG of the E2 gene (primer E22: GGG ACG GTT CTTCAG TCC GGC AGC) (SEQ ID NO:12). This PCR reaction was undertaken withAmpliTaq DNA polymerase according to the manufacturer's recommendationsfor five cycles at 94° C. (30 s), 40° C. (60 s), and 72° C. (30 s)followed by 25 cycles at 94° C. (30 s), 55° C. (60 s) and 72° C. (30 s).This generated a product of 341 bp containing a NcoI site at its leftend and a EcoRI site at its right end comprising the 5′ end of the E2gene without a signal sequence. The fragment was gel purified usingstandard procedures, cleaved with NcoI and EcoRI and ligated into theNcoI and EcoRI sites of pTC191 to obtain pE2.

Plasmid pJT17 was then digested with EcoRI and SacI. The 1.7 kb longfragment containing the 3′ end of the E2 gene was gel purified andligated with pE2, which had previously been digested with EcoRI andSacI, to obtain pCTE2 containing the entire E2 gene without a signalsequence. Plasmid pCTE2 was digested with NcoI and SacI and the 2.0 kblong fragment containing the E2 gene was gel purified and ligated intothe NcoI and SacI sites of pJG203, yielding pTPR1E2 containing the E2gene fused to a 903 bp long tobacco PR-1a promoter fragment (FIG. 1).

Plasmid pTPR1E2 was digested with XhoI and XbaI and the 2.9 kb longfragment containing the chimeric E2 gene construct was gel purified andligated into the XhoI and XbaI sites of pBHYGM to construct pEGL102.

Example A3 Preparation of a Chimeric Gene Containing the T. fusca E5Cellulase Coding Sequence Fused to the Tobacco PR-1a Promoter

Plasmid pD374, a modified version of pD370 (Collmer and Wilson (1983)Biotechnology 1, 594-601; Lao et al. (1991) J. Bacteriol. 173,3397-3407) containing the T. fusca E5 gene (GenBank accession numberL01577), which codes for a protein with endoglucanase activity, was usedas the template for PCR with a left-to-right “top strand” primercomprising an ATG before the first codon of the mature E5 protein, thefirst 21 base pairs of the mature protein and a NcoI restriction site atthe newly created ATG (primer E51: CGC CCA TGG CCG GTC TCA CCG CCA CAGTC) (SEQ ID NO:13) and a right-to-left “bottom strand” primer homologousto positions 89 to 114 from the newly created ATG of the E5 gene (primerE52: GAC GAC CTC CCA CTG GGA GAC GGT G) (SEQ ID NO:14). AmpliTaq DNApolymerase was used for PCR according to the manufacturer'srecommendations for five cycles at 94° C. (30 s), 40° C. (60 s), and 72°C. (30 s) followed by 25 cycles at 94° C. (30 s), 55° C. (60 s) and 72°C. (30 s). This generated a product of 119 bp containing a NcoI site atits left end and a XhoI site at its right end and comprised the 5′ endof the E5 gene without a signal sequence. The fragment was gel purified,cleaved with NcoI and XhoI and ligated into the NcoI and XhoI sites ofpCIB4247 to obtain pCE5. pCIB4247 is a pUC19 derivative (Yanisch-Perronet al. (1985) Gene 33, 103-119) containing a polylinker with NcoI, XhoIand EcoRI restriction sites.

In order to reconstitute the entire E5 gene, a 1.4 kb long XhoI/PvuIIfragment of pD374 containing the E5 gene 3′ end was subcloned into theXhoI and EcoRV sites of pICEM19R+, a pUC19 derivative containing apolylinker with XhoI, EcoRV and EcoRI restriction sites, excised as aXhoI/EcoRI fragment and ligated into the XhoI and EcoRI sites of pCE5 toform pCTE5 containing the entire E5 gene. pCTE5 was digested with EcoRI,the protruding ends of the EcoRI site were filled-in with DNA PolymeraseI Klenow fragment (Promega, Madison, Wis.) and plasmid DNA was furtherdigested with NcoI. The 1.5 kb long fragment containing the E5 gene wasgel purified and ligated into the NcoI and EcoICRI sites of pJG203,yielding pTPR1E5 containing the E5 gene fused to a 903 bp long tobaccoPR-1a promoter (FIG. 1).

Plasmid pTPR1E5 was digested with ApaI, XbaI and SacI and the 2.7 kblong ApaI/XbaI fragment containing the chimeric E5 gene construct wasgel purified and ligated into the ApaI and XbaI sites of pBHYGM toconstruct pEGL105.

Example A4 Preparation of a Chimeric Gene Containing the T. fusca E5Cellulase Coding Sequence Fused to the CaMV 35S Promoter

A 1.5 kb long NcoI/EcoRI fragment of pCTE5 containing the E5 gene andwhose protruding ends had been previously filled-in with Klenow DNAPolymerase was gel purified and ligated into the filled-in EcoRI site ofpCGN1761 between a duplicated CaMV 35S promoter (Kay el al. (1987)Science 236, 1299-1302) and the tml gene termination signals (Ream etal. (1983) Proc. Natl. Acad. Sci. USA 80, 1660-1664), resulting inp35SE5 (FIG. 1). A 4.6 kb long fragment of p35SE5 containing thechimeric gene was inserted into the XbaI site of pBHYGM to obtainpEGL355.

Example A5 Preparation of Chimeric Genes Containing the T. fusca E1Cellulase Coding Sequence Fused to the CaMV 35S Promoter

A 3.3 kb long NcoI (filled in)/SacI fragment of pCTE1 containing the E1gene is gel purified and ligated into the filled-in EcoRI site ofpCGN1761. The chimeric gene containing the E1 coding sequence fused tothe CaMV 35S promoter is inserted into the XbaI site of pBHYGM.

Example A6 Preparation of Chimeric Genes Containing the T. fusca E2Cellulase Coding Sequence Fused to the CaMV 35S Promoter

A 2.0 kb long NcoI (filled in)/SacI fragment of pCTE2 containing the E2gene is gel purified and ligated into the filled-in EcoRI site ofpCGN1761. The chimeric gene containing the E2 coding sequence fused tothe CaMV 35S promoter is inserted into the XbaI site of pBHYGM.

Example A7 Transformation of Tobacco Leaf Discs by A. tumefaciens

The binary vector constructs pEGL101, pEGL102, pEGL105, and pEGL355 weretransformed into A. tumefaciens strain GV3101 (Bechtold, N. et al.(1993), CR Acad. Sci. Paris, Sciences de la vie, 316:1194-1199) byelectroporation (Dower, W. J. (1987), Plant Mol. Biol. Reporter 1:5).The same procedure is used for transformation of tobacco with otherconstructs containing chimeric cellulase genes.

Leaf discs of Nicotiana tabacum cv ‘Xanthi nc’ and of transgenic line“NahG” overexpressing a salicylate hydroxylase gene (Gaffney et al.(1993) Science 261: 754-756) were cocultivated with Agrobacterium clonescontaining the above mentioned constructs (Horsch et al. (1985), Science227: 1229-1231) and transformants were selected for resistance to 50μg/ml hygromycin B. Approximately 50 independent hygromycin lines (T0lines) for each construct were selected and rooted on hormone-freemedium.

Example A8 Transformation of Maize

Maize transformation by particle bombardment of immature embryos isperformed as described by Koziel et al. (Biotechnology 11, 194-200,1993).

Example A9 Transformation of Wheat

Transformation of immature wheat embryos and immature embryo-derivedcallus using particle bombardment is performed as described by Vasil et.al. (Biotechnology 11: 1553-1558,1993) and Weeks et. al. (PlantPhysiology 102: 1077-1084, 1993).

Example A10 Selection of Transgenic Lines with Inducible Cellulase GeneExpression

For each transgenic line, duplicate leaf punches of approximately 2-3cm² were incubated for 2 days in 3 ml ofbenzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester (BTH, 5.6mg/10 ml) or sterile distilled water under ca. 300 μmol/m²/s irradiance.Leaf material was harvested, flash frozen and ground in liquid nitrogen.Total RNA was extracted (Verwoerd et al. (1989) NAR 17, 2362) andNorthern blot analysis was carried out as described (Ward et al. (1991)The Plant Cell 3, 1085-1094) using radiolabelled probes specific foreach cellulase gene.

Transgenic lines with high levels of inducible transgene expression wereallowed to flower and self-pollinate, producing T1 seeds. Ten T1 seedsfor each transgenic lines were germinated in soil and the resultingplants self-pollinated. T2 seeds from these plants were germinated on Tagar medium (Nitsch and Nitsch (1969) Science 163, 85-87) containing 50μg/ml hygromycin B to identify lines homozygous for the selectablemarker and linked transgene.

Example A11 Induction of Cellulase Expression in Transgenic Plants

Seeds of homozygous nuclear transformant lines are germinatedaseptically on T agar medium and incubated at 300 μmol/m²/s irradiancefor approximately 4-6 weeks. Alternatively, seeds are germinated in soiland grown in the greenhouse for approximately 2 months. Material oflines expressing cellulase genes under constitutive expression (CAMV 35Spromoter) is harvested and flash frozen in liquid nitrogen directly,while lines containing cellulase genes fused to the chemically induciblePR-1a promoter are first sprayed with either 1 mg/ml BTH or water,incubated for 1 to 7 days, and material harvested and flash frozen.

Example A12 Determination of Cellulase Content of Transgenic Plants

In order to determine the amount of cellulase present in the tissues oftransgenic plants, chemiluminescent (Amersham) Western blot analysis isperformed according to the manufacturer's instructions and Harlow andLane (1988) Antibodies: A laboratory manual, Cold Spring HarborLaboratory, Cold Spring Harbor using antisera raised against the E1, E2and E5 proteins and purified E1, E2 and E5 protein standards (providedby D. Wilson, Cornell University, Ithaca, N.Y.).

Example A13 Determination of Cellulase Activity in Transgenic Plants

Leaf material is harvested as described above and homogenized in PCbuffer (50 mM phosphate, 12 mM citrate, pH 6.5). A standard curve (10nanomolar to 10 micromolar) is prepared by diluting appropriate amountsof 4-methylumbelliferone (MU, Sigma Cat. No. M1381) in PC buffer.Duplicate 100 μl aliquots of each standard and duplicate 50 μl aliquotsof each sample are distributed to separate wells of a 96-well microtiterplate. 50 μl of 2 mM 4-methylumbelliferyl-b-D-cellobiopyranoside (MUC,Sigma Cat. No. M6018) prepared in PC buffer is then added to each samplewell and the plate is sealed to prevent evaporation and incubated for 30minutes at 55° C. or at other temperatures ranging from 37° C. to 65° C.The reaction is stopped by adding 100 μl of 0.15 M glycine/NaOH (pH10.3) and the MU fluorescence emission at 460 nm resulting fromcellulase activity is measured with a microplate fluorometer (excitationwavelength=355 nm).

B. Vacuole-Targeted Expression of Cellulases

Example B1 Preparation of a Chimeric Gene Containing the T. fusca E5Cellulase Coding Sequence Fused to the Tobacco PR-1a Promoter

Plasmid pD374 containing the T. fusca E5 gene (see Example A3) was usedas template for PCR with a left-to-right “top strand” primer extendingfrom position 1,135 to 1,156 in the E5 gene relative to the endogenousATG and comprising an additional NcoI site at its left end (primer VAC1:CAT GCC ATG GGT GAG GCC TCC GAG CTG TTC C) (SEQ ID NO:15) and aright-to-left “bottom strand” primer whose sequence was homologous tothe 21 last bp of the E5 gene and including 21 bp of a vacuolartargeting sequence derived from a tobacco chitinase gene (Shinshi et al.(1990) Plant Mol. Biol. 14, 357-368, Neuhaus et al. (1991) Proc. Natl.Acad. Sci. USA 88, 10362-10366), the stop codon of the same tobaccochitinase gene and a SacI restriction site (primer VAC2: TGC GAG CTC TTACAT AGT ATC GAC TAA AAG TCC GGA CTG GAG CTT GCT CCG CAC) (SEQ ID NO:16).AmpliTaq DNA polymerase was used for PCR according to the manufacturer'srecommendations for five cycles at 94° C. (30 s), 40° C. (60 s), and 72°C. (30 s) followed by 25 cycles at 94° C. (30 s), 55° C. (60 s) and 72°C. (30 s). This generated a product of 283-bp containing the 3′ end ofthe E5 gene fused to the vacuolar targeting sequence. The fragment wasgel purified, cleaved with NcoI and SacI and ligated into the NcoI andSacI sites of pJG203 to obtain pJGDE5.

Plasmid pD374 was then digested with NcoI and SacI, the 1.1 kb longfragment containing the 5′ end of the E5 gene including the signalsequence gel purified and ligated into the NcoI and SacI sites of pJGDE5to obtain pVACE5 containing the complete E5 gene with signal sequenceand vacuolar targeting sequence fused to a 903 bp long tobacco PR-1apromoter (FIG. 1).

Plasmid pVACE5 was digested with ApaI, XbaI and ScaI and the resulting2.8 kb fragment containing the chimeric E5 gene was gel purified andligated into the ApaI and XbaI sites of pBHYGM to obtain pEGL115.

Example B2 Preparation of a Chimeric Gene Containing the T. fusca E1Cellulase Coding Sequence Fused to the Tobacco PR-1a Promoter

A binary Agrobacterium transformation vector containing the T. fusca E1cellulase coding sequence, its signal sequence, and a vacuolar targetingsequence fused to the tobacco PR-1a promoter is constructed as describedin Example B1 for the T. fusca E5 cellulase coding sequence.

Example B3 Preparation of a Chimeric Gene Containing the T. fusca E2Cellulase Coding Sequence Fused to the Tobacco PR-1 a Promoter

A binary Agrobacterium transformation vector containing the T. fusca E2cellulase coding sequence, its signal sequence, and a vacuolar targetingsequence fused to the tobacco PR-1 a promoter is constructed asdescribed in Example B1 for the T. fusca E5 cellulase coding sequence.

Example B4 Preparation of a Chimeric Gene Containing the T. fusca E5Cellulase Coding Sequence Fused to the CaMV 35S Promoter

Plasmid pVACE5 was digested with NcoI and EcoICRI. The resulting 1.6 kbfragment whose protruding NcoI ends had been previously filled-in withKlenow DNA Polymerase was gel purified and ligated into the filled-inEcoRI site of pCGN1761 to obtain p35SVACE5, containing the E5 gene withsignal sequence and vacuolar targeting sequence fused to the CaMV 35Spromoter (FIG. 1). A 4.7 kb long fragment of p35SE5 containing thechimeric E5 gene was inserted into the XbaI site of pBHYGM to constructpEGL315.

Example B5 Preparation of a Chimeric Gene Containing the T. fusca E1Cellulase Coding Sequence Fused to the CaMV 35S Promoter

A binary Agrobacterium transformation vector containing the T. fusca E1cellulase coding sequence, its signal sequence, and a vacuolar targetingsequence fused the CaMV 35S promoter is constructed as described inExample B4 for the T. fusca E5 cellulase coding sequence.

Example B6 Preparation of a Chimeric Gene Containing the T. fusca E2Cellulase Coding Sequence Fused to the CaMV 35S Promoter

A binary Agrobacterium transformation vector containing the T. fusca E2cellulase coding sequence, its signal sequence, and a vacuolar targetingsequence fused to the CaMV 35S promoter is constructed as described inExample B4 for the T. fusca E5 cellulase coding sequence.

Example B7 Transformation of Tobacco Leaf Discs by A. tumefaciens

The binary vector constructs pEGL115 and pEGL315 were transformed intoA. tumefaciens strain GV3101 (Bechtold, N. et al. (1993), CR Acad. Sci.Paris, Sciences de la vie, 316:1194-1199) by electroporation (Dower, W.J. (1987), Plant Mol. Biol. Reporter 1:5). The same procedure is usedfor transformation of tobacco with other constructs containing chimericcellulase genes.

Leaf discs of Nicotiana tabacum cv ‘Xanthi nc’ and of transgenic line“NahG” overexpressing a salicylate hydroxylase gene (Gaffney et al.(1993) Science 261: 754-756) were cocultivated with Agrobacterium clonescontaining the above mentioned constructs (Horsch et al. (1985), Science227: 1229-1231) and transformants were selected for resistance to 50μg/ml hygromycin B. Approximately 50 independent hygromycin lines (T0lines) for each construct were selected and rooted on hormone-freemedium.

Example B8 Transformation of Maize

Maize transformation by particle bombardment of immature embryos isperformed as described by Koziel et al. (Biotechnology 11, 194-200,1993).

Example B9 Transformation of Wheat

Transformation of immature wheat embryos and immature embryo-derivedcallus using particle bombardment is performed as described by Vasil et.al. (Biotechnology 11: 1553-1558,1993) and Weeks et. al. (PlantPhysiology 102: 1077-1084, 1993).

Example B10 Selection of Transgenic Lines with Inducible Cellulase GeneExpression

For each transgenic line duplicate leaf punches of approximately 2-3 cm²were incubated for 2 days in 3 ml ofbenzo(1,2,3)thiadiazole-7-carbothioic acid S-methyl ester (BTH, 5.6mg/10 ml) or sterile distilled water under ca. 300 μmol/m²/s irradiance.Leaf material was harvested, flash frozen and ground in liquid nitrogen.Total RNA was extracted (Verwoerd et al. (1989) NAR 17, 2362) andNorthern blot analysis was carried out as described (Ward et al. (1991)The Plant Cell 3, 1085-1094) using radiolabelled probes specific foreach cellulase gene.

Transgenic lines with high levels of inducible transgene expression wereallowed to flower and self-pollinate, producing T1 seeds. Ten T1 seedsfor each transgenic lines were germinated in soil and the resultingplants self-pollinated. T2 seeds from these plants were germinated on Tagar medium (Nitsch and Nitsch (1969) Science 163, 85-87) containing 50μg/ml hygromycin B to identify lines homozygous for the selectablemarker and linked transgene.

Example B11 Induction of Cellulase Expression in Transgenic Plants

Seeds of homozygous nuclear transformant lines are germinatedaseptically on T agar medium and incubated at 300 μmol/m²/s irradiancefor approximately 4-6 weeks. Alternatively, seeds are germinated in soiland grown in the greenhouse for approximately 2 months. Material oflines expressing cellulase genes under constitutive expression (CaMV 35Spromoter) is harvested and flash frozen in liquid nitrogen directly,while lines containing cellulase genes fused to the chemically induciblePR-1a promoter are first sprayed with either 1 mg/ml BTH or water,incubated for 1 to 7 days, and material harvested and flash frozen.

Example B12 Determination of Cellulase Content of Transgenic Plants

In order to determine the amount of cellulase present in the tissues oftransgenic plants, chemiluminescent (Amersham) Western blot analysis isperformed according to the manufacturer's instructions and Harlow andLane (1988) Antibodies: A laboratory manual, Cold Spring HarborLaboratory, Cold Spring Harbor using antisera raised against the E1, E2and E5 proteins and purified E1, E2 and E5 protein standards (providedby D. Wilson, Cornell University, Ithaca, N.Y).

Example B13 Determination of Cellulase Activity in Transgenic Plants

1. Fluorometric Assay

Leaf material is harvested as described above and homogenized in PCbuffer (50 mM phosphate, 12 mM citrate, pH 6.5). A standard curve (10nanomolar to 10 micromolar) is prepared by diluting appropriate amountsof 4-methylumbelliferone (MU, Sigma Cat. No. M-1381) in PC buffer.Duplicate 100 μl aliquots of each standard and duplicate 50 μl aliquotsof each sample are distributed to separate wells of a 96-well microtiterplate. 50 μl of 2 mM 4-methylumbelliferyl-b-D-cellobiopyranoside (MUC,Sigma Cat. No. M6018), prepared in PC buffer is then added to each welland the plate is sealed to prevent evaporation and then incubated for 30minutes at the desired temperature (55_C.-60_C. is optimal for T. fuscacellulases). The reaction is stopped by adding 100 μl of 0.15 Mglycine/NaOH (pH 10.3) and the fluorescence emission at 460 nm measuredwith a microplate fluorometer (excitation wavelength=355 nm). In orderto calculate the cellulase specific activity (pmoles MU/mgprotein/minute) the amount of protein in each extract is determinedusing a BCA assay (Pierce, Rockford, Ill.) according to themanufacturer's recommendations.2. CMCase Activity (According to Wilson (1988) Methods in Enzymology,160: 314-315)Leaf material is homogenized in 0.3 ml of 0.05 M potassium phosphatebuffer (pH 6.5) and is incubated with 0.1 ml of carboxymethylcellulose(CMC, Sigma , Cat. No. C-5678) for 15-60 minutes at the desiredtemperature (55_C.-60_C. is optimal for T. fusca cellulases). Afteradding 0.75 ml of DNS reagent (200 g/l sodium potassium tartrate, 10 g/ldinitrosalicylic acid, 2 g/l phenol, 0.5 g/l sodium sulfite, 10 g/lsodium hydroxide) the samples are boiled for 15 minutes. The samples arecooled down and the optical density is measured at 600 nm. The amount ofreducing sugars released from CMC is determined using a glucose standardcurve and the cellulase activity is expressed in mmol glucose equivalentreducing sugar per minute. In order to calculate the specific cellulaseactivity the amount of protein in each extract is determined using a BCAassay (Pierce, Rockford, Ill.) according to the manufacturer'srecommendations.

Alternatively, the cellulase activity on CMC is measured with aviscosity method as described by Durbin and Lewis (1988) Methods inEnzymology, 160: 314-315.

3. Filter Paper Assay (According to Wilson (1988) Methods in Enzymology,160: 314-315, thereby Incorporated by Reference)

Leaf material is homogenized in 0.05 M potassium phosphate buffer (pH6.5) and the resulting extracts are added to a disk of filter paper(Whatman No. 1). After incubation for 4-24 hours at the desiredtemperature (55_C.-60_C. is optimal for T. fusca cellulases), thereaction is stopped and reducing sugars content is determined.Alternatively, the cellulase activity on CMC is measured with aviscosity method as described by Durbin and Lewis (1988) Methods inEnzymology, 160: 314-315.

C. Expression of Cellulase Genes within the Tobacco Chloroplast

Example C1 Preparation of a Chimeric Gene Containing the T. fusca E5Cellulase Coding Sequence Fused to a Modified Bacteriophage T7 Gene 10Promoter and Terminator in Tobacco Plastid Transformation Vector pC8

Plasmid pCTE5 was digested with EcoRI, treated with Klenow DNApolymerase to fill in the recessed 3′ ends, digested with NcoI and theresulting 1.5 kb DNA fragment gel purified and ligated to a 7.5 kb NcoI(cohesive end)/XbaI (filled in) DNA fragment from plastid transformationvector pC8 to create plasmid pC8E5 (FIG. 2). pC8 (Dr. Pal Maliga,Rutgers University, unpublished) is a derivative of plastidtransformation vector pPRV111A (Zoubenko, O. V., Allison, L. A., Svab,Z., and Maliga, P. (1994) Nucleic Acids Res 22, 3819-3824, hereinincorporated by reference in its entirety; GenBank accession numberU12812) that carries a bacterial aminoglycoside-3′-adenyltransferase(aadA) gene conferring spectinomycin resistance under control of theconstitutive tobacco plastid psbA gene promoter and psbA 5′ and 3′untranslated RNA (UTR) sequences. The 3′ end of the aadA cassette inpPRV111A is flanked by 1.8 kb of tobacco plastid DNA containing thecomplete trnV gene and a 5′ portion of the 16S rDNA gene while the 5′end is immediately adjacent to a multiple cloning site (EcoRI, SacI,KpnI, SmaI, BamHI, XbaI, SalI, PstI, SphI, HindIII) which is in turnflanked by the 1.2 kb of plastid DNA containing the ORF 70B gene and aportion of the rps 7/12 operon. These flanking homologous regions serveto target integration of the intervening heterologous DNA into theinverted repeat region of the tobacco plastid genome at nucleotidepositions 102,309 and 140,219 of the published Nicotiana tabacum plastidgenome sequence (Shinozaki, K. et al. (1986) EMBO J. 5, 2043-2049). pC8was obtained by cloning into the EcoRI and HindIII sites of the pPRV111Apolylinker a chimeric E. coli uidA gene encoding β-galacturonidase (GUS)controlled by the bacteriophage T7 gene 10 promoter and terminatorsequences derived from the pET21d expression vector (Novagen, Inc.,Madison, Wis.).

Example C2 Preparation of a Modified Tobacco Plastid TransformationVector Containing the T. fusca E5 Cellulase Coding Sequence Fused to aModified Bacteriophage T7 Gene 10 Promoter and Terminator Engineered forReduced Read-through Transcription

Plasmid pC8 was digested with SpeI and NcoI and a 235 bp fragmentcontaining the T7 gene 10 promoter and a portion of the divergent psbAgene promoter and 5′ UTR was isolated by gel purification and clonedinto the NcoI and SpeI restriction sites of vector pGEM5Zf+ (Promega,Madison Wis.) to construct plasmid pPH118. pPH118 was digested with StuIand the 3210 bp vector fragment gel purified and religated to constructplasmid pPH119 which lacks the duplicated 10 bp sequence CGAGGCCTCG (SEQID NO:17) (StuI site underlined) that was found by sequence analysis tobe present in plasmid pC8. Elimination of the 10 bp StuI/StuI fragmentin pPH119 was verified by sequencing using universal M13 forward andreverse primers.

In order to obtain a non-plastid DNA fragment to use as a spacer betweenthe chimeric psbA/aadA selectable marker gene and the pET21d T7 gene 10promoter in pC8, yeast shuttle vector pRS305 (Sikorski, R. S., andHieter, P. (1989) Genetics 122, 19-27; GenBank accession number U03437)was digested with EcoRI and HincII and a 256 bp fragment of theSaccharomyces cerevisiae LEU2 gene coding sequence isolated and gelpurified. Plasmid pPH119 was digested with EcoRI and DraIII and a 2645bp fragment isolated and gel purified. pPH119 was digested with EcoRI,treated with Klenow DNA polymerase to fill in the overhanging 3′terminus, digested with DraIII and a 569 bp fragment gel purified. Thethree fragments were ligated to create plasmid pPH120 in which the LEU2gene fragment is inserted between the divergent T7 gene 10 and psbApromoters of pPH119.

Plastid transformation vector pC+E5 (FIG. 2) was constructed bydigesting plasmid pPH120 with NcoI/EcoRI and gel purifying a 386 bpfragment, digesting plasmid pC8E5 with NcoI/HindIII and gel purifying a1595 bp fragment, digesting plasmid pC8 with HindIII/EcoRI and gelpurifying a 7287 bp fragment, and ligating the fragments in a 3-wayreaction.

Example C3 Construction of a Plastid-targeted Bacteriophage T7 RNAPolymerase Gene Fused to the Tbacco PR-1a Promoter

A synthetic oligonucleotide linker comprising an NcoI restriction siteand ATG start codon followed by the first seven plastid transit peptidecodons from the rbcS gene (encoding the small subunit of ribulosebisphosphate carboxylase) and endogenous PstI restriction site (topstrand: 5′-CAT GGC TTC CTC AGT TCT TTC CTC TGC A-3′ (SEQ ID NO:18);bottom strand: 5′-GAG GAA AGA ACT GAG GAA GC-3′) (SEQ ID NO:19), a 2.8kb PstI/SacI DNA fragment of pCGN4205 (McBride, K. E. et al. (1994) PNAS91, 7301-7305) containing the bacteriophage T7 RNA polymerase gene (T7Pol) fused in frame to the 3′ portion of the rbcS gene transit peptidecoding sequence, a 0.9 kb NcoI/KpnI DNA fragment of pCIB296 containingthe tobacco PR-1a promoter with an introduced NcoI restriction site atthe start codon (Uknes et al. (1993) Plant Cell 5, 159 169) and 4.9 kbSfiI/KpnI and 6.6 kb SacI/SfiI fragments of binary Agrobacteriumtransformation vector pSGCGC1 (a derivative of pGPTV-Hyg containing thepolylinker from pGEM4 (Promega, Madison Wis.) cloned into theSacI/HindIII sites) were ligated to construct pPH110.

Example C4 Biolistic Transformation of the Tobacco Plastid Genome

Seeds of Nicotiana tabacum c.v. ‘Xanthi nc’ were germinated seven perplate in a 1″ circular array on T agar medium and bombarded in situ12-14 days after sowing with 1 μm tungsten particles (M10, Biorad,Hercules, Calif.) coated with DNA from plasmids pC8E5 and pC+E5essentially as described (Svab, Z. and Maliga, P. (1993) PNAS 90, 913917). Bombarded seedlings were incubated on T medium for two days afterwhich leaves were excised and placed abaxial side up in bright light(350-500 μmol photons/m2/s) on plates of RMOP medium (Svab, Z.,Hajdukiewicz, P. and Maliga, P. (1990) PNAS 87, 8526 8530) containing500 μg/ml spectinomycin dihydrochloride (Sigma, St. Louis, Mo.).Resistant shoots appearing underneath the bleached leaves three to eightweeks after bombardment were subcloned onto the same selective medium,allowed to form callus, and secondary shoots isolated and subcloned.Complete segregation of transformed plastid genome copies to ahomoplastidic state in independent subclones was assessed by standardtechniques of Southern blotting (Sambrook et al., (1989) MolecularCloning: A Laboratory Manual, Cold Springs Harbor Laboratory, ColdSpring Harbor). BamHI/EcoRI-digested total cellular DNA (Mettler, I. J.(1987) Plant Mol Biol Reporter 5, 346-349) was separated on 1%Tris-borate (TBE) agarose gels, transferred to nylon membranes(Amersham) and probed with ³²P-labeled random primed DNA sequencescorresponding to a 0.7 kb BamHI/HindIII fragment from pC8 containing aportion of the rps7/12 plastid targeting sequence. Homoplastidic shootswere rooted aseptically on spectinomycin-containing MS/IBA medium(McBride, K. E. et al., (1994) PNAS 91, 7301-7305) and transferred tothe greenhouse.

Example C5 Introduction of the Chimeric PR-1a/T7 Pol Gene Into theTobacco Nuclear Genome by Agrobacterium-mediated Leaf DiscTransformation

Hygromycin resistant NT-pPH110 tobacco plants were regenerated asdescribed from shoots obtained following cocultivation of leaf disks ofN. tabacum ‘Xanthi’ and “NahG” with GV3101 Agrobacterium carrying thepPH110 binary vector. For each transgenic line duplicate leaf punches ofapproximately 2-3 cm² were incubated for 2 days in 3 ml of BTH (5.6mg/10 ml) or sterile distilled water under ca. 300 μmol/m²/s irradiance.Leaf material was harvested, flash frozen and ground in liquid nitrogen.Total RNA was extracted (Verwoerd et al. (1989) NAR 17, 2362) andNorthern blot analysis was carried out as described (Ward et al. (1991)The Plant Cell 3, 1085-1094) using a radiolabelled T7 RNA polymerasegene probe. Plants of nineteen NT-110X (Xanthi genetic background) andseven NT-110N (NahG genetic background) T1 lines showing a range of T7Pol expression were transferred to the greenhouse and self pollinated.Progeny segregating 3:1 for the linked hygromycin resistance marker wereselfed and homozygous T2 lines selected.

Example C6 Induction of Cellulase Expression in Plastids of TransgenicPlants

Homozygous NT-110X and NT-110N plants containing the PR-1a-T7 RNA Polconstruct were used to pollinate homoplastidic Nt_pC8E5 and Nt_pC+E5plastid transformant lines carrying the maternally inherited pC8E5 andpC+E5 cellulase constructs. The Nt_pC+E5×NT-110X or NT_(—)110N, andNt_pC8E5×NT-110X or NT_(—)110N F1 progeny (which were heterozygous forthe PR-1/T7 polymerase nuclear expression cassette and homoplastidic forthe T7/cellulase plastid expression cassette) were germinated on soil.Upon reaching a height of 20-40 cm, the plants were sprayed with theinducer compound BTH to elicit T7 Pol-regulated expression of the E5cellulase gene that is localized to the plastids. Plant material washarvested just prior to induction and at 8 hours and 1, 2, 3, 7, and 14or 28 days following induction and flash frozen as described above.

Example C7 Determination of E5 Cellulase mRNA Content of TransgenicPlants

Total RNA was extracted from frozen tissue of BTH and wettablepowder-sprayed control and PR-1a/7 polymerase×plastid T7/cellulaseplants, and Northern blot analysis on 5 μg RNA samples was carried outas described (Ward et al. (1991) The Plant Cell 3, 1085-1094) using as aprobe a radiolabelled DNA fragment containing the E5 cellulase codingsequence. Relative E5 cellulase MRNA accumulation at each time point wasassessed by quantifying the radioactivity in bands hybridizing with theradiolabelled E5 cellulase probe in order to determine time courses offold mRNA induction. The transgenic plant material of example C6 showssignificant cellulase mRNA accumulation in this assay followinginduction, peaking at 14 days after induction. Prior to induction, nocellulase MRNA is detected.

Example C8 Determination of Cellulase Content of Transgenic Plants

In order to determine the amount of cellulase present in the tissues oftransgenic plants, chemiluminescent (Amersham) Western blot analysis isperformed according to the manufacturer's instructions and Harlow andLane (1988) Antibodies: A laboratory manual, Cold Spring HarborLaboratory, Cold Spring Harbor using antisera raised against the E5protein and purified E5 protein standards (provided by D. Wilson,Cornell University, Ithaca, N.Y). The transgenic plant material ofexample C6 shows significant cellulase expression and accumulation inthis assay following induction (ca. 0.3% of total soluble protein at 14days after induction; no detectible protein prior to induction).

Example C9 Determination of Cellulase Activity in Transgenic Plants

Leaf material is harvested as described above and homogenized in PCbuffer (50 mM phosphate, 12 mM citrate, pH 6.5). A standard curve (10nanomolar to 10 micromolar) is prepared by diluting appropriate amountsof 4-methylumbelliferone (MU, Sigma Cat. No. M1381) in PC buffer.Duplicate 100 μl aliquots of each standard and duplicate 50 μl aliquotsof each sample are distributed to separate wells of a 96-well microtiterplate. 50 μl of 2 mM 4-methylumbelliferyl-b-D-cellobiopyranoside (MUC,Sigma Cat. No. M6018) prepared in PC buffer is then added to each samplewell and the plate is sealed to prevent evaporation and incubated for 30minutes at 55° C. or at other temperatures ranging from 37° C. to 65° C.The reaction is stopped by adding 100 μl of 0.15 M glycine/NaOH (pH10.3) and the fluorescence emission at 460 nm measured with a microplatefluorometer (excitation wavelength=355 nm).

Example C10 Induction of GUS Expression in Plastids of Transgenic Plants

The N. tabacum ‘Xanthi’ plastid transformant line 4276P described byMcBride et al. ((1994) PNAS 91: 7301-7305) was pollinated by homozygousNT-110X6b-5 plants containing the PR-1a/T7 RNA polymerase. 4276P differsfrom pC8 only with respect to (a) the promoter used to express the aadAselectable marker (which has the 16S ribosomal RNA gene promoter ratherthan the psbA gene promoter used in pC8), (b) the presence of a psbAgene 3′ untranslated region between the GUS gene and the T7 terminator,and (c) the absence of a lac operator and duplicated StuI restrictionsite sequence in the T7 promoter. F1 plants from this cross heterozygousfor the PR-1a/T7 polymerase nuclear expression cassette andhomoplastidic for the T7/GUS plastid expression cassette were germinatedin soil. Upon reaching a height of 20 to 40 cm the plants were sprayedwith either an inert wettable powder suspension or a formulation of theinducer compound BTH with wettable powder. Control untransforned N.tabacum ‘Xanthi’, NT-110X6b-5, and 4276P plants germinated in soil atthe same time were sprayed in a similar manner. Plant material (one leaffrom each of three independent plants of each genotype) was harvestedjust prior to spraying and at 8 hours and 1, 2, 3, 7, and 28 daysfollowing spraying, and flash frozen as described above.

Example C11 Determination of GUS MRNA Content of Transgenic Plants

Total RNA was extracted from frozen tissue of BTH and wettablepowder-sprayed control and PR-1a/T7 polymerase×plastid T7/GUS plants,and Northern blot analysis on 5 μg RNA samples was carried out asdescribed (Ward et al. (1991) The Plant Cell 3, 1085-1094) using as aprobe a 500 bp radiolabelled 5′ fragment of the GUS gene. GUS mRNAaccumulation at each time point was assessed by quantifying theradioactivity in bands hybridizing with the radiolabelled GUS probe, aswell as by scanning the ethidium-bromide fluorescence present in theprominent RNA band which became visible starting at the 3 day post-spraytime point and which was observed to co-migrate with the hybridizing GUSRNA band on Northern blots. Chemically inducible GUS RNA in the plastidwas observed to reach a peak level of 14% of total ethidium-stainableRNA (this includes all RNA species present in the plant, including thenon-protein coding ribosomal RNA which makes up a majority of thestainable plant RNA) between 7 and 28 days after induction with BTH (seeTable 1) and is much higher (over 1000-fold) than the peak chemicallyinducible GUS mRNA accumulation for nuclear PR- I a/GUS transformants.

Example C12 Determination of GUS Protein Content of Transgenic Plants

In order to determine the amount of GUS present in the tissues oftransgenic plants, chemiluminescent (Amersham) Western blot analysis wasperformed according to the manufacturer's instructions and Harlow andLane (1988) Antibodies: A laboratory manual, Cold Spring HarborLaboratory, Cold Spring Harbor, using GUS antisera purchased fromMolecular Probes and purified GUS protein standards (Sigma). Proteinsfrom frozen, ground leaf material harvested as above were solubilized byextraction in 50 mM Tris pH 8.0, 1 mM EDTA, 1 mM PTT, 1 mM AEBSP, and 1mM DTT and 5 to 25 μg protein run on each lane of 10% polyacrylamidegels. GUS protein accumulation in the plastid transformed plants issustained over 7-28 days and beyond, and is extraordinarily high (muchhigher than peak GUS accumulation for nuclear PR-1a/GUS), exceeding 20%of of total protein by 28 days. By comparison, GUS protein accumulationin the nuclear PR1a/GUS transformants peaks somewhat earlier (about 3days from induction, rather than 7-28 days) and the protein accumulationis not sustained, but declines to the limits of detection by 28 days.

Example C13 Determination of GUS Activity in Transgenic Plants

Frozen leaf tissue was ground in a mortar with a pestle in the presenceof liquid nitrogen to produce a fine powder. Leaf extracts were preparedin GUS extraction buffer (50 mM sodium phosphate pH7.0, 0.1% Triton-X100, 0.1% sarkosyl, 10 mM beta-mercaptoethanol) as described byJefferson, R. A. et al. (1986), PNAS USA 83, 8447-8451. The reactionswere carried out in the wells of opaque microtiter plates by mixing 10ul of extract with 65 ul of GUS assay buffer (50 mM sodium phosphate pH7.0, 10 mM EDTA, 0.1% Triton X-100, 10 mM beta-mercaptoethanol)containing 4-methyl umbelliferyl glucuronide (MU) at a finalconcentration of 2 mM in a total volume of 75 ul. The plate wasincubated at 37° C. for 30 minutes and the reaction was stopped by theaddition of 225 ul of 0.2 M sodium carbonate. The concentration offluorescent indicator released was determined by reading the plate on aFlow Labs Fluoroskan II ELISA plate reader. Duplicate fluorescencevalues for each sample were averaged, and background fluorescence(reaction without MUG) was subtracted to obtain the concentration of MUfor each sample. The amount of protein in each extract was determinedusing the bicinchoninic acid technique (BCA, Pierce Biochemicals)according to the manufacturer's recommendations except that proteinextracts were pretreated with iodacetamide (Sigma) to eliminatebackground signal caused by the reductant (beta-mercaptoethanol) presentin the extraction buffer. The specific activity was determined for eachsample and was expressed in pmoles MU/mg protein/minute. For each tissuesample assayed from a particular time point following BTH application,the specific activity of the BTH-induced sample was divided by thespecific activity of the pre-BTH treatment control sample, thus yieldingthe induction of GUS expression. (See Table 1)

TABLE I pPH110X6b × 4276P: Induction of GUS RNA and GUS Activity bySpraying with BTH GUS activity (pmol Fold Induction % Total FoldInduction Days + BTH MU/mg/min) (GUS activity) RNA (GUS RNA) 0.0 598 1<0.013 1 0.3 434 0.7 <0.013 24 1.0 14,516 24 0.108 959 2.0 230,031 3800.873 1,897 3.0 456,486 749 2.663 2,396 7.0 2,424,725 3,999 7.745 2,87528.0 1,922,466 3,106 24.596 3,392

1. A transgenic plant comprising a nucleic acid encoding a microbialβ-1,4-endoglucanase (EC 3.2.1.4), wherein said nucleic acid is stablyintegrated into the nuclear genome of a cell of the plant and is underthe control of a promoter active in a plant, wherein the promoter is aninducible promoter.
 2. The transgenic plant of claim 1, wherein themicrobial β1,4-endoglucanase is thermostable.
 3. The transgenic plant ofclaim 1, wherein the microbial β-1,4-endoglucanase is from acellulolytic bacterium.
 4. The transgenic plant of claim 1, wherein themicrobial β-1,4-endoglucanase is from a filamentous fungus.
 5. Thetransgenic plant of claim 1, wherein the promoter is a wound induciblepromoter.
 6. The transgenic plant of claim 1, wherein the promoter is achemically-inducible promoter.
 7. A transgenic plant comprising anucleic acid encoding a microbial β-1,4-endoglucanase (EC 3.2.1.4),wherein said nucleic acid is stably integrated into the nuclear genomeof a cell of the plant and is under the control of a promoter active ina plant, wherein the promoter is a wound inducible or achemically-inducible promoter.
 8. A transgenic seed comprising a nucleicacid encoding a microbial β-1,4-endoglucanase (EC 3.2.1.4), wherein saidnucleic acid is stably integrated into the nuclear genome of a cell ofthe seed and is under the control of a promoter active in a plant,wherein the promoter is an inducible promoter.
 9. A transgenic plantcomprising a nucleic acid encoding a microbial β-1,4-endoglucanase (EC3.2.1.4) and a targeting sequence, wherein the nucleic acid is stablyintegrated into the nuclear genome of a cell of the plant and is undercontrol of a promoter active in a plant and wherein the targetingsequence targets the microbial β-1,4-endoglucanase to a compartmentselected from the group consisting of vacuole, chloroplast,mitochondria, peroxisome, apoplast, and ER.
 10. The transgenic plant ofclaim 9, wherein the promoter determines a spatial or temporalexpression pattern for the microbial β-1,4-endoglucanase.
 11. Thetransgenic plant of claim 9, wherein the promoter is an induciblepromoter.
 12. The transgenic plant of claim 11, wherein the promoter isa wound inducible promoter.
 13. The transgenic plant of claim 11,wherein the promoter is a chemically-inducible promoter.
 14. Thetransgenic plant of claim 9, wherein the microbial β1,4-endoglucanase isthermostable.
 15. The transgenic plant of claim 9, wherein the microbialβ-1,4-endoglucanase is from a cellulolytic bacterium.
 16. The transgenicplant of claim 9, wherein the microbial β-1,4-endoglucanase is from afilamentous fungus.
 17. A transgenic seed comprising a nucleic acidencoding a microbial β-1,4-endoglucanase (EC 3.2.1.4) and a targetingsequence, wherein the nucleic acid is stably integrated into the nucleargenome of a cell of the seed and is under control of a promoter activein a plant and wherein the targeting sequence targets the microbialβ-1,4-endoglucanase to a compartment selected from the group consistingof vacuole, chloroplast, mitochondria, peroxisome, apoplast, and ER. 18.A transgenic plant comprising a nucleic acid encoding a microbialβ-1,4-endoglucanase (EC 3.2.1.4), wherein the nucleic acid is stablyintegrated into a plastid genome of the plant and is under control of aninducible promoter.
 19. The transgenic plant of claim 18, wherein themicrobial β-1,4-endoglucanase is from a cellulolytic bacterium.
 20. Thetransgenic plant of claim 18, wherein the microbial β-1,4-endoglucanaseis from a filamentous fungus.
 21. The transgenic plant of claim 18,wherein the promoter is a chemically inducible promoter.
 22. Thetransgenic plant of claim 18, wherein the promoter is a wound induciblepromoter.
 23. The transgenic plant of claim 18, wherein the microbialβ-1,4-endoglucanase is thermostable.
 24. A transgenic seed comprising anucleic acid encoding a microbial β-1,4-endoglucanase (EC 3.2.1.4),wherein the nucleic acid is stably integrated into a plastid genome ofthe plant and is under control of an inducible promoter.
 25. Atransgenic plant comprising a nucleic acid encoding a microbialβ-1,4-endoglucanase (EC 3.2.1.4) from a Thermomonospora bacterium,wherein said nucleic acid is stably integrated into the nuclear genomeof a cell of the plant and is under the control of a promoter active ina plant, wherein the promoter is an inducible promoter.
 26. Thetransgenic plant of claim 25, where in the microbial β-1,4-endoglucanaseis from T. fusca.
 27. A transgenic plant comprising a nucleic acidencoding a microbial β-1,4-endoglucanase (EC 3.2.1.4) is from aThermomonospora bacterium, wherein the nucleic acid is stably integratedinto a plastid genome of the plant and is under control of an induciblepromoter.
 28. The transgenic plant of claim 27, wherein the microbialβ1,4-endoglucanase is from T. fusca.